Latest Funding Opportunity Guides

  • Advanced Materials & Manufacturing

  • Aerospace & Spacetech

  • Agtech & Foodtech

  • Artificial Intelligence & Machines Learning

  • Biotech

  • Cleantech & Climatetech

  • Cybersecurity

  • Defensetech & Dual-Use Tech

  • eXtended Reality

  • Healthtech

  • Medtech

  • Other Tech

  • Quantum & Photonics

  • Robotics & Autonomous Systems

Inactive, Broad Topic Josiah Wegner Inactive, Broad Topic Josiah Wegner

Request for Information (RFI) Special Notice DARPA-SN-26-96 Advancing Autonomous Science for Biological Applications DARPA BTO

Deadline: Closed

Funding Award Size: Under $2m

Description: Learn about DARPA's Advancing Autonomous Science for Biological Applications RFI (DARPA-SN-26-96), including eligibility, response requirements, research topics, submission deadline, and how organizations can help shape future DARPA programs.

Updated October 2026: This opportunity is closed. The deadline for this opportunity has passed. Browse currently open opportunities in our funding database.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

Application deadline: July 22, 2026, at 5:00 p.m. Eastern Time (ET). This is a Request for Information (RFI) issued by the Defense Advanced Research Projects Agency (DARPA) Biological Technology Office (BTO)—not a funding opportunity or solicitation for proposals. DARPA is seeking input from the scientific and technical community on the current state of autonomous science for biological applications, key technical challenges, and future investment opportunities that could inform future DARPA programs. Organizations with expertise in autonomous science, AI, robotics, laboratory automation, and related technologies should consider submitting a response before July 22, 2026, at 5:00 p.m. Eastern Time (ET) to help shape potential future research initiatives.

How much funding would I receive?

This RFI does not provide funding. Award amounts, contract values, or grant funding are not specified because this is an information-gathering request rather than a solicitation for proposals. This information can be used to apply to the DARPA BTO Broad Agency Announcement for awards under $2 million.

REQUESTED INFORMATION:

Responses should address Informatics Technologies, Physical Technologies, or Both Informatics and Physical Technologies for autonomous science. In each case, a response must address at least one of the following research areas:

1. Current state of the art of autonomous science and transformational enabling technologies to advance that state of the art

  • Key existing enabling technologies broadly transferrable across scientific workflows.

  • Technologies in development that will be transformational in enabling autonomous science.

  • Metrics of success for judging the current state of the art and emerging technologies to surpass it (e.g., throughput, reproducibility, power usage, continuous runtime, cost per assay, etc.).

2. Key technical, organizational, or operational bottlenecks in deploying autonomous science at scale or in new domains

  • Challenges to enabling rapid development and exchange of new autonomous workflows, including equipment or assays that provide unique challenges to automation.

  • Challenges to interoperability between laboratories and the exchange of data and protocols.

  • Measures of success in promoting more efficient, effective, and portable workflow development.

3. Application areas in which new investments could have the greatest impact and best demonstrate the unique advantages of autonomous science to solve problems not amenable to conventional approaches

  • Problems of national interest where autonomous science can achieve results infeasible via conventional science, including specific applications for national security.

  • Enabling technologies available or emerging to achieve those results.

  • Metrics for establishing improvement over conventional approaches.

  • Current commercialization strategies and business cases for future development of autonomous science.

4. Safety and security considerations in the operation of highly automated laboratories and ways these might be addressed, for example through simulation, AI digital twins, or formal verification

  • Risks to safety and security in the operation of autonomous laboratories.

  • Current safeguards, system-level security, traceability, and other approaches to biosecurity.

  • Enabling technologies to resolve these risks.

  • Measures of success for safe operation.

5. New technologies, opportunities, and challenges for maximizing productive interaction between human operators and autonomous agents in hybrid human-AI workflows

  • Applications of national interest that can be achieved only by humans augmented by autonomous scientific facilities.

  • Key barriers to productive interaction between human scientists and autonomous laboratories or their AI agents.

  • Enabling technologies to overcome these barriers.

  • Metrics of success demonstrating the advancement of human-machine partnering over unassisted human or purely autonomous systems.

Are there any additional benefits I would receive?

Submitting a response gives organizations an opportunity to:

  • Provide input that may influence future DARPA program development.

  • Share perspectives on the current state of autonomous science in biological domains.

  • Highlight emerging technologies, technical challenges, commercialization strategies, and national security applications.

Entities that have not previously worked with DARPA are also encouraged to engage with DARPAConnect, which offers educational resources, one-on-one guidance, and outreach to help organizations understand how to engage with DARPA.

What is the timeline to apply and when would I receive funding?

Response deadline: July 22, 2026, at 5:00 p.m. Eastern Time (ET).

Responses must be submitted electronically in PDF format to AutoSci-RFI@darpa.mil.

There is no funding timeline because this is an RFI rather than a funding opportunity. DARPA states that responses may be used to inform future program development, but no subsequent solicitation schedule is provided.

Where does this funding come from?

This RFI was issued by the Defense Advanced Research Projects Agency (DARPA), Biological Technology Office (BTO).

Because this is an RFI, no funding source or funding program is specified.

Who is eligible to apply?

DARPA welcomes responses from all capable sources, including but not limited to:

  • Private companies

  • Public companies

  • Individuals

  • Universities

  • University-affiliated research centers

  • Not-for-profit research institutions

  • U.S. Government-sponsored laboratories

Who is not eligible to apply?

The RFI does not specify any excluded applicant categories.

However:

  • Classified information must not be submitted.

  • DARPA encourages submission of non-proprietary information, and proprietary information must be clearly marked if included.

What companies and projects are likely to win?

This is not a competitive funding opportunity, so there are no awards or winners.

DARPA is seeking responses addressing one or more research areas related to autonomous science, including:

  • State-of-the-art autonomous science technologies

  • Technical, organizational, and operational bottlenecks

  • High-impact application areas

  • Safety and security for autonomous laboratories

  • Human-autonomous system collaboration

Responses may focus on:

  • Informatics Technologies

  • Physical Technologies

  • Both Informatics and Physical Technologies

How competitive will this solicitation be?

DARPA states that this RFI is issued solely for information and program planning purposes and does not constitute a formal solicitation for proposals or proposal abstracts. Responses are voluntary and will not result in a contract or funding.

Are there any restrictions I should know about?

Key submission requirements include:

  • Responses are limited to 7 pages maximum using 12-point font, 1-inch margins, and standard letter-sized pages.

  • Responses must be submitted as an unprotected Microsoft Word document or PDF.

  • Classified information must not be included.

  • Proprietary information must be clearly labeled.

  • DARPA will not reimburse response preparation costs.

  • Responses are voluntary.

  • Proposal abstracts or formal proposals submitted in response to this RFI will be disregarded.

  • DARPA is under no obligation to acknowledge or provide feedback on submissions.

How long will it take me to prepare an application?

Responses must include:

  • A one-page cover page

  • Up to three pages describing the technical approach

  • One page of references

  • Optional summary slides

Organizations should also identify which technology category and research area(s) their response addresses.

How can BW&CO help?

BW&CO can help organizations prepare a concise, DARPA-ready RFI response by:

  • Aligning your response with DARPA's requested research areas.

  • Clearly articulating technical capabilities, challenges, and proposed solutions.

  • Developing commercialization and national security narratives where supported by your technical work.

  • Ensuring compliance with formatting, page limits, and submission requirements.

  • Producing a polished submission designed to communicate your organization's expertise effectively.

Additional Resources

Review the solicitation here.

Read More
Inactive, Broad Topic Josiah Wegner Inactive, Broad Topic Josiah Wegner

CDMRP: FY26 Reconstructive Transplant Research Program (RTRP)

Deadline: Closed

Funding Award Size: Up to $200k

Description: The FY26 Reconstructive Transplant Research Program Concept Award provides up to $200,000 for innovative vascularized composite allotransplantation research. Applications due September 16, 2026.

Updated October 2026: This opportunity is closed. The FY26 application cycle for this program has closed. See our CDMRP guide for the next fiscal year’s announcements. Browse currently open opportunities in our funding database.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The FY26 Reconstructive Transplant Research Program (RTRP) Concept Award supports highly innovative, high-risk research that could open new directions in reconstructive transplantation. The program is designed to fund new concepts and untested theories rather than incremental advances to existing work. Projects must address at least one FY26 RTRP Focus Area and be relevant to improving outcomes for catastrophically injured Service Members, Veterans, their families, caregivers, clinicians, and the American public. Clinical trials are not allowed.

This is a relatively small, early-stage funding opportunity intended to help researchers generate foundational insights that could lead to future development and larger follow-on efforts. The Defense Health Agency expects to fund approximately three awards. The application deadline is 11:59 p.m. ET, September 16, 2026. Organizations interested in applying should begin preparing immediately because a required Letter of Intent must be submitted first by 5:00 p.m. Eastern Time (ET), September 2, 2026.

How much funding would I receive?

Applicants may request up to $200,000 in total costs for the entire project period. The maximum period of performance is 18 months.

The FY26 RTRP expects to allocate approximately $0.6 million to fund approximately three Concept Award applications.

Cost sharing is not required.

What could I use the funding for?

Funding is intended to support highly innovative research addressing important problems in reconstructive transplantation and vascularized composite allotransplantation (VCA). The award specifically supports exploration of new concepts and untested theories rather than continuation of established research programs.

Projects must address at least one of the following FY26 RTRP Focus Areas:

  • Improve or optimize VCA immunosuppression.

  • Identify and/or validate prognostic or diagnostic biomarkers, methods, or tools for monitoring VCA graft rejection and immunosuppression.

  • Advance VCA preservation strategies.

  • Develop tools for measuring VCA outcomes, including performance-based, patient-reported, and neurocognitive outcomes.

Allowable costs may include:

  • Research activities supporting the proposed project.

  • Travel supporting multi-institutional collaborations.

  • Travel for one investigator to present project findings at one scientific or technical meeting per year.

  • Required travel for the Principal Investigator to present results at one Department of War-sponsored meeting during the award period.

Are there any additional benefits I would receive?

In addition to funding, awardees gain the opportunity to conduct research within a Department of Defense-funded program focused on advancing reconstructive transplantation and improving outcomes for catastrophically injured Service Members and Veterans.

Award recipients may also be invited to present project progress at annual RTRP In-Progress Review meetings.

What is the timeline to apply and when would I receive funding?

Key dates include:

  • Letter of Intent deadline: 5:00 p.m. Eastern Time (ET), September 2, 2026

  • Full application deadline: 11:59 p.m. ET, September 16, 2026

  • End of application verification period: 5:00 p.m. ET, September 21, 2026

  • Peer review: November 2026

  • Programmatic review: January 2027

Awards supported with FY26 funds will be made no later than September 30, 2027.

Where does this funding come from?

This funding opportunity is offered through the Defense Health Agency Contracting Activity (DHACA) and managed by the Congressionally Directed Medical Research Programs (CDMRP) as part of the Reconstructive Transplant Research Program (RTRP).

Congress initiated the RTRP in 2012 to support research that refines reconstructive transplantation approaches and expands access to reconstructive transplants and immunotherapy. The FY26 appropriation for the RTRP is $12 million.

Who is eligible to apply?

Eligible applicant organizations include:

  • Extramural and intramural U.S. Department of War organizations.

  • Foreign organizations.

  • Domestic organizations.

  • For-profit organizations.

  • Nonprofit organizations.

  • Public entities.

  • Private entities.

Eligible Principal Investigators include:

  • Investigators at or above the level of postdoctoral fellow.

  • Investigators affiliated with an eligible organization.

  • Investigators regardless of ethnicity, nationality, or citizenship status.

  • Investigators from academic or non-academic organizations.

An investigator may serve as PI on no more than two FY26 RTRP Concept Award applications.

Who is not eligible to apply?

The solicitation states that:

  • Individuals cannot receive awards directly because awards are made to organizations.

  • Investigators below the level of postdoctoral fellow are not eligible to serve as PI.

  • Investigators serving as PI on more than two FY26 RTRP Concept Award applications are not eligible beyond the first two submissions received.

Applications may also be administratively withdrawn if:

  • A clinical trial is proposed.

  • Human subjects or specimen studies do not qualify for exempt or expedited review.

  • The PI does not meet eligibility requirements.

  • Required pre-application materials are not submitted.

What companies and projects are likely to win?

The program is seeking projects that are:

  • Highly innovative.

  • High-risk with the potential to reveal new avenues of investigation.

  • Focused on at least one FY26 RTRP Focus Area.

  • Relevant to military health and catastrophic injury recovery.

  • Supported by a strong scientific rationale despite the absence of preliminary data.

  • Designed with rigorous and reproducible research methods.

Applications leveraging findings from solid organ transplantation for testing in VCA may be competitive when the rationale and potential benefits are clearly justified.

The review criteria place the greatest emphasis on:

  1. Innovation

  2. Relevance

  3. Research Strategy and Feasibility

  4. Personnel

  5. Transition Plan

  6. Research Sharing Plan

  7. Budget

  8. Environment

  9. Application Presentation

How competitive will this solicitation be?

This appears to be a highly competitive opportunity.

The program expects to fund approximately three awards from a total funding pool of approximately $0.6 million.

The solicitation also notes that since FY15, the RTRP Concept Award mechanism has received 196 applications, with 26 recommended for funding.

Are there any restrictions I should know about?

Key restrictions include:

  • Clinical trials are not allowed.

  • Preliminary data cannot be included.

  • Research involving human subjects or specimens must qualify for exempt status or expedited review.

  • Projects involving painful research using domestic cats or dogs are not supported except for studies relating to military or service animals.

  • Classified research data or research likely to generate classified outcomes may result in withdrawal.

  • Duplicate submissions of the same research project within the RTRP during the same fiscal year are prohibited.

How long will it take me to prepare an application?

The application process includes both:

  1. A required Letter of Intent submission.

  2. A full application package.

The solicitation does not specify how long preparation will take. However, applicants must prepare multiple application components, including a Project Narrative, Statement of Work, Innovation Statement, Post-Award Transition Plan, budget materials, supporting documentation, and other required forms.

How can BW&CO help?

BW&CO can help your team:

  • Evaluate whether your concept aligns with one or more FY26 RTRP Focus Areas.

  • Position your project around the program’s primary review criteria, particularly innovation and military relevance.

  • Develop a compliant Letter of Intent and full application package.

  • Build a compelling research strategy and transition plan.

  • Prepare budgets, supporting documentation, and submission materials.

  • Manage the application process through submission and compliance review.

Additional Resources

Review the solicitation here.

Read More
Inactive, Broad Topic Josiah Wegner Inactive, Broad Topic Josiah Wegner

CDMRP: FY26 Rare Cancers Research Program (RCRP)

Deadline: Closed

Funding Award Size: Up to $1.12m

Description: The FY26 Rare Cancers Research Program offers Department of Defense funding through Concept Awards, Idea Development Awards, and Resource and Community Development Awards supporting rare cancer biology, therapies, AI/ML, research platforms, and community infrastructure.

Updated October 2026: This opportunity is closed. The FY26 application cycle for this program has closed. See our CDMRP guide for the next fiscal year’s announcements. Browse currently open opportunities in our funding database.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The FY26 Rare Cancers Research Program (RCRP) is a Department of Defense-funded grant program that supports research on cancers affecting six or fewer persons per 100,000 people per year in the United States. The program aims to improve outcomes for people with rare cancers through discovery, community building, and expansion of knowledge across the cancer landscape. Research must be relevant to Service Members, Veterans, military beneficiaries, and the American public.
RCRP offers three separate funding opportunities in FY26:

• Concept Award – supports highly innovative, untested, potentially groundbreaking ideas.
• Idea Development Award – supports promising research ideas that are ready for further development and could generate high-impact findings.
• Resource and Community Development Award – supports development of research resources, datasets, infrastructure, and community-building platforms for rare cancers research.

Applicants interested in the Idea Development Award or Resource and Community Development Award must submit a required preproposal by 5:00 p.m. Eastern Time (ET), August 19, 2026. Applicants interested in the Concept Award must submit a required Letter of Intent by 5:00 p.m. Eastern Time (ET), September 16, 2026, and a full application by 11:59 p.m. ET, September 30, 2026.

How much funding would I receive?

Funding depends on the award mechanism selected:

Concept Award

  • Up to $140,000 total costs

  • Maximum period of performance: 2 years

  • Approximately 18 awards expected

Idea Development Award

  • Up to $490,000 total costs

  • Maximum period of performance: 3 years

  • Approximately 15 awards expected

Resource and Community Development Award

  • Up to $1.12 million total costs

  • Maximum period of performance: 4 years

  • Approximately 5 awards expected

What could I use the funding for?

Projects must address rare cancers and align with one or more FY26 RCRP focus areas.

Concept Award and Idea Development Award focus areas

  • Biology

  • Preclinical Research Models

  • Therapy, including drug repurposing

  • Artificial Intelligence (AI) and Machine Learning (ML) Models
    Resource and Community Development Award focus areas

  • Platform Development

  • Artificial Intelligence (AI) and Machine Learning (ML) Models

Examples of activities supported under the Resource and Community Development Award include:

  • Biospecimen repositories

  • Patient registries

  • Databases and centralized data-sharing platforms

  • Omics resources

  • Longitudinal natural history studies

  • Resource-sharing infrastructure

  • AI/ML-enabled discovery platforms

Are there any additional benefits I would receive?

In addition to funding, successful applicants gain access to a nationally recognized Department of Defense cancer research program focused on advancing rare cancers research and improving outcomes for patients, Service Members, Veterans, and their families.

The Resource and Community Development Award specifically supports the creation of lasting research resources, stakeholder networks, and community infrastructure intended to continue benefiting the field beyond the award period.

What is the timeline to apply and when would I receive funding?

Concept Award

  • Letter of Intent Deadline: 5:00 p.m. Eastern Time (ET), September 16, 2026

  • Full Application Deadline: 11:59 p.m. ET, September 30, 2026

  • Peer Review: December 2026

  • Programmatic Review: March/April 2027

  • Awards supported with FY26 funds will be made no later than September 30, 2027.

Idea Development Award

  • Preproposal Deadline: 5:00 p.m. Eastern Time (ET), August 19, 2026

  • Invitation to Submit Full Application: September 30, 2026

  • Full Application Deadline: 11:59 p.m. ET, November 18, 2026

  • Peer Review: February 2027

  • Programmatic Review: March/April 2027

  • Awards supported with FY26 funds will be made no later than September 30, 2027.

Resource and Community Development Award

  • Preproposal Deadline: 5:00 p.m. Eastern Time (ET), August 19, 2026

  • Invitation to Submit Full Application: September 30, 2026

  • Full Application Deadline: 11:59 p.m. ET, November 18, 2026

  • Peer Review: February 2027

  • Programmatic Review: March/April 2027

  • Awards supported with FY26 funds will be made no later than September 30, 2027.

Where does this funding come from?

The Rare Cancers Research Program is managed by the Congressionally Directed Medical Research Programs (CDMRP) within the Defense Health Agency Research and Development organization. Congress established the program in 2020 to support research of exceptional scientific merit in rare cancers. The FY26 appropriation is $17.5 million.

Who is eligible to apply?

Eligible applicants include:

  • Foreign and domestic organizations

  • For-profit organizations

  • Nonprofit organizations

  • Public entities

  • Private entities

  • Extramural and intramural organizations
    Principal Investigator eligibility varies by mechanism:

Concept Award

  • Independent investigators at or above the level of postdoctoral fellow (or equivalent)

Idea Development Award

  • Independent investigators at all career levels

Resource and Community Development Award

  • Independent investigators at all career levels

Who is not eligible to apply?

The solicitation does not provide additional eligibility exclusions beyond the stated organizational and investigator requirements.

However:

  • Awards are made to organizations, not individuals. - An investigator may only serve as Principal Investigator on one application within each FY26 RCRP award mechanism.

What companies and projects are likely to win?

The strongest applications will closely align with the intent of the selected mechanism.

Concept Award

  • Highly innovative, untested, potentially groundbreaking concepts

  • High-risk ideas that open entirely new avenues of investigation

  • Novel approaches that challenge existing paradigms in rare cancers research

Idea Development Award

  • Research supported by preliminary data

  • Projects with strong scientific rationale

  • Ideas capable of generating high-impact findings and major advancements in rare cancers research

Resource and Community Development Award

  • Platforms, datasets, repositories, and infrastructure that fill major gaps in rare cancers research

  • Projects with strong plans for community engagement, dissemination, sustainability, and resource sharing

  • Efforts that can benefit multiple rare cancer types or subtypes

How competitive will this solicitation be?

The program is expected to be highly competitive.

Historical data provided in the solicitations show:

Concept Award

  • 979 applications received

  • 90 recommended for funding

Idea Development Award

  • 862 applications received

  • 85 recommended for funding

Resource and Community Development Award

  • 103 applications received

  • 23 recommended for funding

Are there any restrictions I should know about?

Across all three mechanisms:

  • Clinical trials are not allowed. - Projects must focus on cancers affecting six or fewer persons per 100,000 people per year in the United States. - Research must be relevant to Service Members, Veterans, military beneficiaries, and the American public.
    Additional Resource and Community Development Award requirements include:

  • At least two rare cancer Patient Advocates must participate as integral members of the research team.

  • Community building, dissemination, and sustainability plans are required.

How long will it take me to prepare an application?

Preparation effort depends on the mechanism selected.

Concept Award

  • Requires a Letter of Intent and a short blinded application package.

  • Generally expected to require the least preparation effort of the three mechanisms.

Idea Development Award

  • Requires a preproposal followed by an invited full application.

  • Preliminary data with disease-specific rationale are required.
    Resource and Community Development Award

  • Requires a preproposal followed by an invited full application.

  • Requires extensive planning around community engagement, patient advocacy, dissemination, sustainment, and resource-sharing infrastructure.

How can BW&CO help?

BW&CO can support applicants with:

  • Opportunity assessment and mechanism selection

  • Eligibility and project fit review

  • Preproposal and Letter of Intent development

  • Full proposal writing and editing

  • Scientific and commercialization positioning

  • Reviewer-focused narrative development

  • Patient advocate engagement strategy

  • Budget development and compliance review

  • Final submission support

Additional Resources

Review the solicitation here.

Read More
Inactive, Broad Topic Josiah Wegner Inactive, Broad Topic Josiah Wegner

CDMRP: FY26 Kidney Cancer Research Program (KCRP)

Deadline: Closed

Funding Award Size: Up to $1.2m

Description: The FY26 Kidney Cancer Research Program offers three Department of Defense funding opportunities, including the Concept Award, Idea Development Award, and Academy of Kidney Cancer Investigators Early-Career Scholar Award, providing up to $1.2 million for innovative kidney cancer research.

Updated October 2026: This opportunity is closed. The FY26 application cycle for this program has closed. See our CDMRP guide for the next fiscal year’s announcements. Browse currently open opportunities in our funding database.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Department of Defense Congressionally Directed Medical Research Programs (CDMRP) has released three Fiscal Year 2026 Kidney Cancer Research Program (KCRP) funding opportunities designed to support innovative kidney cancer research, develop future leaders in the field, and accelerate new discoveries that improve outcomes for patients. Collectively, these opportunities represent approximately $10.2 million in anticipated funding across three award mechanisms.

The FY26 KCRP continues to focus on advancing the biology of kidney cancer, developing new therapeutic approaches, improving patient care and survivorship, addressing health disparities, and expanding research capacity through investigator development and collaboration.

Researchers can apply through one of three mechanisms:

Concept Award
Supports highly innovative, untested, and potentially groundbreaking ideas in kidney cancer research. This mechanism is intended for high-risk concepts that could open entirely new avenues of investigation. Preliminary data are not allowed. Awards provide up to $120,000 in total costs over one year.

Idea Development Award
Supports hypothesis-driven research projects backed by preliminary data and a well-developed scientific rationale. Projects must address important questions in kidney cancer research or clinical care and demonstrate potential for significant impact. Awards provide up to $900,000 for a single Principal Investigator or up to $1.2 million through the Partnering Principal Investigator option over three years.

Academy of Kidney Cancer Investigators – Early-Career Scholar Award
Supports promising early-career investigators pursuing independent careers in kidney cancer research. In addition to funding a research project, awardees join a national mentoring and networking academy that provides intensive mentorship, scientific collaboration opportunities, leadership development, and career support. Awards provide up to $1.2 million over four years.

All three mechanisms require submission of a Letter of Intent prior to full application submission and do not allow clinical trials. Applicants should begin preparing immediately to ensure sufficient time for project development, institutional approvals, collaborator coordination, and application assembly.

The earliest deadline is the Concept Award Letter of Intent due July 28, 2026, 5:00 p.m. Eastern Time. The Idea Development Award and Academy of Kidney Cancer Investigators – Early-Career Scholar Award both require Letters of Intent by September 14, 2026, 5:00 p.m. Eastern Time.

How much funding would I receive?

Funding depends on the mechanism selected.

Concept Award

  • Up to $120,000 total costs

  • Maximum period of performance: 1 year

  • Approximately 7 awards anticipated

Idea Development Award

  • Single PI Option: Up to $900,000 total costs

  • Partnering PI Option: Up to $1.2 million total costs

  • Maximum period of performance: 3 years

  • Approximately 8 awards anticipated

Academy of Kidney Cancer Investigators – Early-Career Scholar Award

  • Up to $1.2 million total costs

  • Maximum period of performance: 4 years

  • Approximately 2 awards anticipated

What could I use the funding for?

All three mechanisms support research addressing at least one FY26 KCRP focus area, including:

  • Understanding kidney cancer biology, progression, metastasis, and prevention

  • Developing new screening, diagnostic, prognostic, and imaging approaches

  • Advancing treatments for rare kidney cancers

  • Creating novel therapeutic strategies

  • Improving quality of life and survivorship

  • Addressing outcomes in high-risk and underserved populations

  • Expanding research capacity and developing future kidney cancer researchers

The Concept Award is intended for exploratory, high-risk concepts.

The Idea Development Award supports mature research projects with preliminary data and a clearly defined hypothesis.

The Early-Career Scholar Award supports both a research project and a structured career-development program designed to establish long-term independence in kidney cancer research.

Are there any additional benefits I would receive?

The Idea Development Award includes a Partnering Principal Investigator option that supports formal collaborations between two investigators contributing distinct expertise to a single project.

The Academy of Kidney Cancer Investigators – Early-Career Scholar Award provides:

  • Intensive mentorship from established kidney cancer investigators

  • National networking opportunities

  • Scientific collaborations

  • Monthly academy programming

  • Annual and biennial workshops

  • Leadership and career development training

  • Access to a national peer network of kidney cancer researchers

All three mechanisms encourage multidisciplinary collaborations involving academia, industry, the Department of Defense, the Department of Veterans Affairs, and other federal agencies.

What is the timeline to apply and when would I receive funding?

Concept Award

  • Letter of Intent Deadline: July 28, 2026, 5:00 p.m. Eastern Time

  • Application Deadline: August 11, 2026, 11:59 p.m. Eastern Time

  • Peer Review: October 2026

  • Programmatic Review: December 2026

Idea Development Award

  • Letter of Intent Deadline: September 14, 2026, 5:00 p.m. Eastern Time

  • Application Deadline: September 28, 2026, 11:59 p.m. Eastern Time

  • Peer Review: December 2026

  • Programmatic Review: March 2027

Academy of Kidney Cancer Investigators – Early-Career Scholar Award

  • Letter of Intent Deadline: September 14, 2026, 5:00 p.m. Eastern Time

  • Application Deadline: September 28, 2026, 11:59 p.m. Eastern Time

  • Peer Review: December 2026

  • Programmatic Review: March 2027

Awards funded through FY26 appropriations are expected to be made no later than September 30, 2027.

Where does this funding come from?

Funding comes from the Department of Defense Congressionally Directed Medical Research Programs through the Kidney Cancer Research Program.

Congress established the KCRP in 2017 to support research with exceptional scientific merit and high potential impact. The program received $15 million in FY26 appropriations.

The program's mission is to promote rigorous, innovative, high-impact kidney cancer research for the benefit of Service Members, Veterans, their families, and the American public.

Who is eligible to apply?

Concept Award

  • Investigators at all career levels, including postdoctoral fellows or equivalent

  • Foreign and domestic organizations

  • For-profit and nonprofit organizations

  • Public and private entities

Idea Development Award

  • Investigators at or above the level of Assistant Professor (or equivalent)

  • Foreign and domestic organizations

  • For-profit and nonprofit organizations

  • Public and private entities

Academy of Kidney Cancer Investigators – Early-Career Scholar Award

  • Investigators within seven years of their most recent postdoctoral research position, clinical fellowship, or equivalent

  • Must meet Early-Career Scholar eligibility requirements

  • Must identify a qualified Designated Mentor

  • Foreign and domestic organizations

  • For-profit and nonprofit organizations

  • Public and private entities

Who is not eligible to apply?

Concept Award

  • Investigators below the postdoctoral fellow level (or equivalent)

Idea Development Award

  • Investigators below the Assistant Professor level (or equivalent)

Academy of Kidney Cancer Investigators – Early-Career Scholar Award

  • Individuals currently in postdoctoral positions, clinical fellowships, or equivalent training positions at the application deadline

  • Investigators more than seven years removed from their last postdoctoral position, fellowship, or equivalent training experience

Additional eligibility restrictions apply to mentors participating in the Academy mechanism.

What companies and projects are likely to win?

Competitive applications will closely align with KCRP priorities and demonstrate clear potential to advance the field.

For the Concept Award, reviewers are looking for:

  • Highly innovative ideas

  • Novel concepts

  • New research paradigms

  • Research that goes beyond incremental advances

For the Idea Development Award, reviewers are looking for:

  • Strong preliminary data

  • Well-developed hypotheses

  • Rigorous research strategies

  • Significant potential impact on kidney cancer research or patient care

For the Early-Career Scholar Award, reviewers are evaluating:

  • The investigator's potential to become an independent leader in kidney cancer research

  • Quality of the mentoring plan

  • Strength of the career-development strategy

  • Scientific merit of the proposed research

Across all mechanisms, projects that directly address FY26 KCRP focus areas and demonstrate strong scientific rationale are likely to be most competitive.

Are there any restrictions I should know about?

Across all three mechanisms:

  • Clinical trials are not allowed.

  • Applications must address at least one FY26 KCRP focus area.

  • Applications must address at least one eligible kidney cancer disease type.

  • Cost sharing is not required.

  • Awards are made to organizations rather than individuals.

Additional mechanism-specific restrictions include:

Concept Award

  • Preliminary data are not allowed.

  • Applications undergo blinded review.

  • Applications may not contain identifying information about investigators or institutions.

Idea Development Award

  • Preliminary data are required.

Academy of Kidney Cancer Investigators – Early-Career Scholar Award

  • Preliminary data are required.

  • Applicants must meet specific career-stage requirements.

  • Applicants must identify an eligible Designated Mentor.

How competitive will this solicitation be?

The FY26 KCRP funding opportunities are expected to be highly competitive.

Historical funding data demonstrates significant demand:

Concept Award

  • 587 applications received since FY17

  • 73 recommended for funding

Idea Development Award

  • 610 applications received since FY17

  • 124 recommended for funding

Academy of Kidney Cancer Investigators – Early-Career Scholar Award

  • 40 applications received since FY19

  • 14 recommended for funding

Applicants should expect strong competition and should clearly demonstrate alignment with program priorities, innovation, feasibility, and potential impact.

How long will it take me to prepare an application?

Preparation effort varies significantly by mechanism.

Concept Award
Typically requires the least preparation because preliminary data are prohibited and the narrative is intentionally brief. However, applicants must carefully comply with blinded-review requirements.

Idea Development Award
Requires substantial preparation due to the need for preliminary data, a comprehensive research strategy, detailed supporting documentation, impact statements, and progression planning.

Academy of Kidney Cancer Investigators – Early-Career Scholar Award
Typically requires the greatest preparation effort because applicants must develop both a research plan and a comprehensive career-development strategy while coordinating mentor participation and institutional commitments.

How can BW&CO help?

BW&CO can help applicants determine which KCRP mechanism best aligns with their technology, scientific maturity, and career stage.

Our team can support:

  • Opportunity assessment and go/no-go decisions

  • Mechanism selection

  • Research strategy development

  • Hypothesis refinement

  • Innovation positioning

  • Impact narrative development

  • Mentor and collaborator coordination

  • Compliance review

  • Proposal writing and editing

  • Grants.gov and submission support

Additional Resources

Review the solicitation here.

Read More
Active, Broad Topic Josiah Wegner Active, Broad Topic Josiah Wegner

National Science Foundation (NSF) Small Business Innovation Research Program (NSF SBIR/STTR)

Deadline: November 4th, 2026 (then March 4th and July 7th, 2027)

Funding Award Size: $305K + $1.25M+ in follow-on funding

Description: Apply for NSF SBIR/STTR funding for high-risk, high-impact technologies. U.S. startups can receive up to $305K in Phase I funding and up to $1.25M in Phase II. Project Pitch submissions begin June 2, 2026.

Updated October 2026: NSF has posted a new SBIR/STTR Phase I solicitation (NSF 26-510). Upcoming deadlines are November 4, 2026, March 4, 2027, and July 7, 2027. An invited Project Pitch is still required before you submit a full proposal.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The NSF SBIR/STTR program provides non-dilutive funding to U.S.-based startups and small businesses developing high-risk, high-impact technologies with strong commercial potential. NSF states it funds “nearly everything from biotechnology to wireless communications to quantum to semiconductors.” Companies begin by submitting a required Project Pitch to determine fit with the program before being invited to submit a full proposal.

NSF began accepting new Project Pitches under the current solicitations (NSF 26-510 and 26-511) on Tuesday, June 2, 2026. Full proposal submission deadlines are:

  • November 4 2026

  • March 4 2027

  • July 7 2027

Proposal submission is due by 5:00 PM submitter’s time on the specified due date. November 4, 2026 is also the last date NSF lists for two transition groups: companies with an unused Project Pitch invitation issued on or after July 3, 2025, and Phase I awardees whose award started on or after November 6, 2023 and who have not yet submitted a Phase II proposal.

NSF emphasizes that the program is intended for technologies requiring substantial high-risk R&D and not “straightforward engineering or incremental product development tasks.” The process is highly competitive, with historical NSF SBIR/STTR Phase I funding rates between 10% and 20%.

How much funding would I receive?

If your proposal is awarded, NSF states you may receive:

  • Up to $305,000 for a Phase I award.

  • Up to $1,250,000 over two years for a Phase II award.

NSF does not set award minimums, and voluntary committed cost sharing is prohibited. Fast-Track awards, new at NSF, combine both phases for up to $1,555,555, including $400,000 for the Phase I portion. NSF 26-510 anticipates about $210 million in total, with roughly 180 SBIR and 50 STTR Phase I awards, 80 SBIR and 10 STTR Phase II awards, and 15 SBIR and 3 STTR Fast-Track awards. Each company can receive up to $2 million in NSF SBIR/STTR R&D funding, and NSF has no Direct-to-Phase II option.

What could I use the funding for?

NSF states funding is intended for:

  • High-risk research and development

  • Deep technologies

  • Foundational science and engineering innovations

  • New products, services, and scalable solutions

  • Technologies with strong commercial potential and societal impact

The program specifically supports technologies that:

  • Require substantial technical innovation

  • Address significant societal or national problems

  • Create sustainable competitive advantages

  • Demonstrate meaningful market pull and scalability

NSF explicitly states it does not fund:

  • Straightforward engineering

  • Incremental product development tasks

Example Technology Areas (NSF funds nearly all technology areas and does not solicit specific technologies)

Are there any additional benefits I would receive?

Additional benefits described in the solicitation materials include:

  • Access to external technical and commercialization reviewers

  • Feedback from NSF experts and review panels

  • Eligibility for supplemental funding opportunities after Phase II

  • Ability to apply for additional NSF funding after successful Phase I progress

NSF also notes that access to most Phase I award funds occurs at the time of award notification.

What is the timeline to apply and when would I receive funding?

Application process timeline:

  1. Complete the Project Pitch Assessment

  2. Submit a required Project Pitch

  3. Receive a response from NSF in approximately 1–2 months

  4. If invited, submit a full proposal

  5. Undergo proposal review and due diligence

  6. Receive funding decision approximately 5–7 months after proposal submission deadline

Full proposal submission deadlines are:

  • November 4 2026

  • March 4 2027

  • July 7 2027

Proposal submission is due by 5:00 PM submitter’s time on the specified due date.

NSF states:

  • Proposal review occurs approximately 1–3 months after submission

  • Additional due diligence may occur approximately 3–5 months after submission

  • Funding decisions occur approximately 5–7 months after submission

Where does this funding come from?

The funding comes from:

  • The U.S. National Science Foundation (NSF)

  • America’s Seed Fund

  • NSF SBIR/STTR programs

The solicitation references:

  • NSF 26-510: Small Business Innovation Research / Small Business Technology Transfer Phase I, Phase II, Fast-Track Programs SBIR/STTR: Developing Deep Technologies that Advance U.S. Competitiveness and Security

  • NSF 26-511: Small Business Innovation Research / Small Business Technology Transfer Phase I, Phase II, Fast-Track Programs: A Pilot Emphasis on Scientific Instrumentation

Who is eligible to apply?

To be eligible, companies must:

  • Be a small business with 500 or fewer employees, including affiliates

  • Be located in the United States

  • Be at least 51% owned and controlled by U.S. citizens or permanent residents

  • Perform all funded work in the United States

  • Employ the Principal Investigator (PI) more than 50% at the company (outside employment above 19.6 hours a week is a conflict)

  • Have the PI commit at least one month of work per six months of project duration (three months per six months for Fast-Track)

NSF states it does not fund:

  • Companies majority-owned by one or more venture capital operating companies

  • Companies majority-owned by private equity firms

  • Companies majority-owned by hedge funds

The PI does not need advanced degrees.

What companies and projects are likely to win?

NSF states it looks for companies and projects with:

  • Strong technological innovation

  • High-risk, unproven R&D

  • Significant societal or national impact

  • Sustainable competitive advantages

  • Commercial potential and market pull

  • Scalable business opportunities

  • Technically qualified and commercially motivated teams

NSF specifically evaluates:

  • Intellectual Merit

  • Broader Impacts

  • Commercial Impact

The solicitation materials state that proposals are reviewed by external technical and commercialization experts in addition to NSF program staff.

Are there any restrictions I should know about?

Important restrictions and requirements include:

  • Each company may submit one Project Pitch per submission window, have one under review at a time, submit at most two in any 12-month period and three total for the same project. An invitation is valid for the next two full-proposal deadlines, and each company may submit one full proposal per deadline.

  • Companies with a pending Project Pitch, Open Invitation, or proposal under review must wait before submitting another Project Pitch

  • All funded work, including consultant and contractor work, must occur in the United States

  • SAM registration is required before proposal submission

  • SAM registration can take up to three weeks to complete

  • Proposal submission is due by 5:00 PM submitter’s time on the specified due date

NSF also notes that:

  • An invitation to submit a proposal does not guarantee funding

  • Historical Phase I funding rates have been between 10% and 20%

How long will it take me to prepare an application?

The solicitation materials do not specify a required preparation timeline.

However, NSF states:

  • Writing a full proposal requires a “significant investment of time and effort”

  • Companies should begin registration processes “as soon as possible”

  • SAM registration can take up to three weeks

  • Research.gov registration can take up to 48 hours

The application process includes:

  • Completing a Project Pitch

  • Receiving NSF feedback

  • Preparing a full proposal if invited

  • Completing multiple federal registrations

How can BW&CO help?

BW&CO can help companies:

  • Assess fit with NSF SBIR/STTR evaluation criteria

  • Develop a compelling Project Pitch

  • Position the technical innovation and commercial potential clearly

  • Draft and manage the full NSF proposal process

  • Prepare commercialization and market positioning content

  • Coordinate registrations and submission workflows

  • Improve competitiveness against NSF review criteria

How much would BW&CO Charge?

Our full service support is available for a flat fee of $9,000 + 5% Success Fee.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

Learn more about the program here.

Read More
Active Josiah Wegner Active Josiah Wegner

NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) - PA-27-100

Deadline: January 5th, 2027

Funding Award Size: <$2.1 Million

Description: NIH, CDC, and FDA Parent SBIR (PA-27-100) offers up to $700K Phase I and $3M Phase II non-dilutive funding. See eligibility, deadlines, and how BW&CO can help you apply.

Updated October 2026: NIH replaced the parent SBIR announcement with PA-27-100. The next standard due date is January 5, 2027, followed by April 5, 2027.

Executive Summary:

The NIH, CDC, and FDA jointly award up to $2.1 million per company through the SBIR Program (NIH additionally runs the parallel STTR Program) to support U.S. small businesses developing innovative health, biomedical, and life science technologies. Companies can apply for Phase I (proof-of-concept), Phase II (R&D and commercialization), Fast-Track, Phase IIB (follow-on), or the Commercialization Readiness Pilot (CRP) for late-stage commercialization support. Applications are due January 5, April 5, and September 5 each year, with funding typically beginning 9 months after submission. Companies should begin preparing applications at least 12 weeks before a due date to complete required federal registrations.

Note: CDC does not accept STTR, Fast-Track, Direct-to-Phase II, Phase IIB, or CRP applications. FDA does not participate in STTR at all and does not accept Fast-Track, Direct-to-Phase II, Phase IIB, CRP, or clinical trial applications through either program.

How much funding would I receive?

Standard guidelines provide up to $323,090 for Phase I (typically 1–2 years) and $2,153,927 for Phase II (typically 2–3 years). Many NIH Institutes and Centers (ICs) have approval to exceed these caps for specific research priorities. For example:

  • NIA allows up to $700,000 (Phase I) and $3 million (Phase II) for Alzheimer's disease and AD-related dementia (AD/ADRD) projects, and up to $500,000/$2.5 million for other projects in its mission space.

  • NIGMS allows Phase IIB budgets up to $3 million, or $4 million for Strategic Breakthrough awards involving clinical trials.

  • NCI supports CRP projects (including clinical trials and validation studies) up to the SBA statutory maximum of $4,191,495, plus up to $500,000 for technical assistance.

  • NIEHS caps its Superfund Research Program topics at $200,000 (Phase I) / $1.25 million (Phase II) / $300,000 (CRP), and its Worker Training Program topics at $100,000 (Phase I only).

Fast-Track and Phase IIB options allow continuous or extended funding beyond Phase II, though acceptance of Phase IIB and CRP applications varies by Institute or Center (see below).

What could I use the funding for?

Funds support research and development toward a commercially viable product or service aligned with the mission of a specific NIH Institute or Center, CDC program, or FDA center. Eligible costs include personnel, materials, prototypes, testing, IP protection, and other R&D expenses. Phase II, Phase IIB, and CRP funds may also cover scale-up, clinical validation, regulatory preparation (including IND/IDE-enabling studies), and commercialization activities.

Does NIH SBIR/STTR fund clinical trials?

It depends on the Institute or Center. Most ICs with a direct clinical mission (NCI, NHLBI, NIA, NICHD, NIDA, NIMH, NINDS, NIMHD, NIDDK, and others) accept clinical trials through their SBIR and/or STTR programs, and several (NCI, NHLBI, NIA, NICHD, NIGMS, NIMH, NINDS, NIMHD) accept them through Phase IIB as well. A smaller number of ICs, including NIAMS, NIDCR, and NIBIB (limited to early-stage, feasibility-only trials), do not accept clinical trials or restrict them significantly. CDC accepts clinical trials through its SBIR program; FDA does not accept clinical trials through either program. Applicants planning human subjects research, including IDE- or IND-enabling studies, should confirm their target IC's specific policy and connect with program staff before submission, since sequencing (e.g., IDE/IRB timing relative to Phase I/II milestones) varies significantly by IC.

What is the Commercialization Readiness Pilot (CRP)?

CRP is a late-stage, milestone-driven award intended for companies that are close to market and need targeted, non-dilutive funding to complete specific commercialization steps, such as clinical trials, manufacturing scale-up, or regulatory submissions. Most (but not all) NIH ICs participate; CDC and FDA do not. Where offered, CRP budgets and eligible use cases vary considerably by IC, as shown above.

Are there any additional benefits I would receive?

Beyond the award itself, recipients gain:

  • Government validation and credibility that builds investor and partner confidence.

  • Enhanced visibility through NIH and HHS award announcements.

  • Access to the federal innovation ecosystem, including potential collaboration with NIH labs and federal health programs.

  • Stronger commercial and exit potential, since non-dilutive funding matures technology, de-risks commercialization, and increases attractiveness for acquisition or follow-on private investment.

What is the timeline to apply and when would I receive funding?

Open Date (Earliest Submission Date): August 05, 2026.

Application Deadlines (all due by 5:00 PM local time of applicant organization):

  • September 05, 2026

  • January 05, 2027

  • April 05, 2027

For the September 05, 2026 submission cycle:

  • Scientific Merit Review: November 2026

  • Advisory Council Review: January 2027

  • Earliest Start Date: April 2027

For the January 05, 2027 submission cycle:

  • Scientific Merit Review: March 2027

  • Advisory Council Review: May 2027

  • Earliest Start Date: July 2027

For the April 05, 2027 submission cycle:

  • Scientific Merit Review: July 2027

  • Advisory Council Review: August 2027

  • Earliest Start Date: December 2027

The first application deadline is September 05, 2026 by 5:00 PM local time of applicant organization. No late applications will be accepted.

Where does this funding come from?

Funding comes from the U.S. Department of Health and Human Services through participating organizations including:

  • National Institutes of Health (NIH)

  • Centers for Disease Control and Prevention (CDC)

  • U.S. Food and Drug Administration (FDA)

The SBIR program is a congressionally mandated program that supports commercialization of innovative technologies developed by U.S. small businesses. NIH, CDC, and FDA set aside a portion of their extramural research budgets to fund SBIR awards.

Who is eligible to apply?

Applicants must be U.S. small business concerns (SBCs) that:

  • Are organized for profit with a U.S. place of business.

  • Have ≤ 500 employees including affiliates.

  • Are > 50% owned by U.S. citizens or permanent residents, qualifying U.S. entities, or combinations thereof.

What companies and projects are likely to win?

The NOFO states that reviewers evaluate applications based on:

  • Significance

  • Investigator(s)

  • Innovation

  • Approach

  • Environment

Strong applications are likely to:

  • Address an important unmet health, scientific, or public health need

  • Demonstrate strong scientific and technical merit

  • Present a compelling commercialization opportunity

  • Show a clear path toward product development and market adoption

  • Align closely with the mission and priorities of the target NIH Institute, CDC Center, or FDA Center

  • Be led by a qualified team with the expertise needed to execute the proposed work

For Phase II and Fast-Track applications, commercialization potential and market opportunity are specifically evaluated.

Are there any restrictions I should know about?

Key restrictions include:

  • Only U.S. small businesses are eligible.

  • Foreign organizations are not eligible.

  • Applications involving foreign subawards or subcontracts will not be considered for funding.

  • Clinical trials are not accepted by certain participating Institutes and Centers, including NIAMS, NIDCR, NCATS, ORIP, and all participating FDA Centers under this NOFO.

  • Cost sharing is not required.

  • Companies must satisfy applicable SBA performance benchmark requirements.

  • Duplicate or highly overlapping applications are not permitted.

  • Phase I projects generally require at least 67% of research effort to be performed by the small business.

  • Phase II projects generally require at least 50% of research effort to be performed by the small business.

Additional national security, foreign relationship, and foreign ownership restrictions apply and may result in denial of award.

How long will it take me to prepare an application?

For a first-time applicant, preparing a competitive submission will likely take 120–200 hours in total.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development.

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations.

  • Identify the right IC and mechanism (Phase I, Phase II, Fast-Track, Phase IIB, or CRP) for your project's stage and clinical trial needs, and position your company for long-term growth.

Additional Resources

Review the solicitation here.



Read More
Active, Broad Topic Josiah Wegner Active, Broad Topic Josiah Wegner

Engage SOF (eSOF) Capabilities of Interest – U.S. Special Operations Command (USSOCOM)

Deadline: Rolling deadline until December 31, 2026

Funding Award Size: Est. $500K to $5M

Description: Rolling submission program connecting commercial technologies to USSOCOM needs across AI, ISR, cyber, mobility, medical, and more, with multiple non-dilutive funding pathways.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

USSOCOM is accepting submissions through its Engage SOF (eSOF) process, the digital front door for industry engagement with U.S. Special Operations Command. Companies with technologies that directly address published Capabilities of Interest (CoIs) can submit solutions for potential assessment, experimentation, prototyping, acquisition, or other engagement pathways.

The application deadline is 31 Dec 2026 : 22:59 CST.

USSOCOM states that solutions matching published CoIs will be prioritized for assessment and potential pathway navigation. Technologies that do not align with current CoIs are encouraged to wait for future releases that may be a better fit. Current interests span aviation, communications, cyber, AI, autonomy, ISR, human performance, mobility, medical technologies, power systems, soldier systems, weapons, and other mission-critical areas supporting Special Operations Forces.

How much funding would I receive?

Estimated $500K to $5 Million - Funding is not fixed. Awards vary depending on the pathway and may include contracts, OTAs, SBIR/STTR, CRADAs, or prize competitions.

What could I use the funding for?

The solicitation does not provide direct grant funding parameters. Instead, USSOCOM is seeking commercial technologies that address published Capabilities of Interest.

Areas of interest include:

  • Aviation Systems

  • Biometrics and Forensics

  • Command, Control, Communications, and Computers (C4)

  • Cyberspace Operations

  • Human Performance/Human Machine Interface

  • Information Operations

  • Intelligence, Surveillance, and Reconnaissance (ISR)

  • Irregular Warfare

  • Medical

  • Canine Medicine

  • Mobility

  • Power and Energy

  • Soldier Systems

  • Weapons and Electronic Attack

Examples of capabilities sought include:

  • AI-enabled decision support

  • Edge computing

  • Human performance optimization

  • Wearable sensors

  • Counter-UAS technologies

  • Autonomous systems

  • Cyber operations capabilities

  • Advanced communications

  • ISR platforms and analytics

  • Medical technologies

  • Power and energy solutions

  • Mobility and survivability systems

Applicants should review the published Capabilities of Interest and clearly explain how their solution supports one or more CoIs.

Are there any additional benefits I would receive?

Potential benefits include:

  • Assessment by USSOCOM subject matter experts

  • Feedback on submitted capabilities

  • Potential referral to relevant USSOCOM stakeholders

  • Potential follow-on engagement opportunities

Potential pathways identified by USSOCOM include:

  • OTA for research projects or prototype projects (10 U.S. Code Sections 4021, 4022)

  • Procurement for experimental purposes (10 U.S. Code Section 4023)

  • Cooperative Research and Development Agreement (CRADA) (15 U.S. Code Section 3710a)

  • Prizes for advanced technology achievements (10 U.S. Code Section 4025)

  • Prize competitions (15 U.S. Code Section 3719)

  • FAR-based procurement contracts

USSOCOM does not guarantee that submissions will advance through all stages of the Engage SOF process.

What is the timeline to apply and when would I receive funding?

Open Date:

26 Mar 2026 : 14:00 CDT

Application Deadline:

31 Dec 2026 : 22:59 CST

After submission, USSOCOM describes the following process:

  1. Initial review for completeness, relevance, and CoI alignment.

  2. Assessment by subject matter experts.

  3. Feedback to submitters.

  4. Potential referral and follow-on engagement activities.

The solicitation does not specify:

  • Evaluation timelines

  • Selection timelines

  • Award timelines

  • Contract award dates

  • Funding disbursement dates

Where does this funding come from?

This opportunity is sponsored by U.S. Special Operations Command (USSOCOM).

The Engage SOF process supports the USSOCOM Warfighting Acquisition System by sourcing, screening, and matching commercial technologies to validated Special Operations Forces capability interests.

Who is eligible to apply?

Based on the solicitation, organizations with commercial technologies that address published USSOCOM Capabilities of Interest may submit Scout Cards through the Engage SOF process.

Submissions should:

  • Address one or more published CoIs

  • Demonstrate technology maturity, readiness, and application

  • Satisfy USSOCOM organizational and operational security standards

  • Contain only UNCLASSIFIED information

Who is not eligible to apply?

The solicitation does not explicitly identify ineligible applicant categories.

However, USSOCOM states that:

  • Information submitted through the process must be UNCLASSIFIED.

  • Solutions that do not match published Capabilities of Interest may not be prioritized for assessment.

  • Submissions must satisfy applicable organizational and operational security requirements.

What companies and projects are likely to win?

USSOCOM states that submissions will be prioritized when they:

  • Directly address published Capabilities of Interest

  • Demonstrate evidence of technology maturity

  • Demonstrate readiness and operational applicability

  • Support current SOF challenges

  • Address validated SOF warfighter needs

  • Meet organizational and operational security requirements

The strongest submissions will clearly explain how their technology aligns with specific CoIs and provide evidence supporting effectiveness, maturity, and mission relevance.

How competitive will this solicitation be?

Competition level is not specified.

However, USSOCOM indicates that:

  • Solutions aligned with published Capabilities of Interest will receive priority consideration.

  • Assessment prioritization depends on alignment with current interests and stakeholder demand.

  • Not all submissions will advance through the Engage SOF process.

Organizations whose technologies closely match current CoIs are likely to be in a stronger position than companies submitting capabilities outside published interest areas.

Are there any restrictions I should know about?

Key restrictions include:

  • All information submitted must be UNCLASSIFIED.

  • Solutions should align with published Capabilities of Interest.

  • USSOCOM may share submissions with government experts outside headquarters for evaluation and feedback.

  • Capabilities may be subject to security reviews.

  • Potential pathways may require:

    • CMMC compliance

    • Protection of Controlled Unclassified Information (CUI)

    • Facility Clearance (FCL) requirements for classified applications

    • Compliance with organizational and operational security standards

How long will it take me to prepare an application?

The solicitation does not specify an application preparation timeline.

Applicants should expect to:

  • Review the current Capabilities of Interest document

  • Identify applicable CoIs

  • Prepare evidence demonstrating technology maturity and readiness

  • Explain operational relevance to SOF needs

  • Complete a Scout Card submission through the Engage SOF platform

Preparation effort will depend on the maturity of the technology and the amount of supporting documentation available.

How can BW&CO help?

BW&CO can help you:

  • Determine whether your technology aligns with current USSOCOM Capabilities of Interest

  • Position your solution against specific CoIs

  • Develop a compelling Scout Card submission

  • Strengthen evidence of technical maturity and operational relevance

  • Prepare supporting materials for USSOCOM review

  • Support follow-on OTA, CRADA, SBIR/STTR, experimentation, or acquisition opportunities if interest is generated through the Engage SOF process

Additional Resources

Review the solicitation here (Requires Login).

Read More
Inactive, Broad Topic Josiah Wegner Inactive, Broad Topic Josiah Wegner

Product Development Funding Programs – Cancer Prevention and Research Institute of Texas (CPRIT)

Deadline: Closed

Funding Award Size: Est. $500K to $10M

Description: Flexible, non-dilutive funding for Texas-based companies or those willing to relocate to Texas developing innovative cancer technologies, including AI, bioinformatics, and emerging platform approaches.

Updated October 2026: This opportunity is closed. The C-27.1 cycle has closed and its RFAs are archived. No next cycle has been released yet. Browse currently open opportunities in our funding database.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

CPRIT provides flexible, non-dilutive funding to support the development and commercialization of innovative cancer technologies. Through four distinct programs—SEED, TDDC, TTC, and TNTC—CPRIT funds companies across the full lifecycle, from early-stage discovery to late-stage clinical development. Preliminary applications are due April 16, 2026, with full applications due July 9, 2026.

How much funding would I receive?

Funding varies by program:

  • SEED Awards: Up to ~$3 million (early-stage)

  • TDDC, TTC, TNTC: No fixed cap; funding is flexible and negotiated based on project scope

CPRIT allocates approximately $70 million annually for company investments and distributes funding through milestone-based contracts tied to project progress

What could I use the funding for?

Funding supports research and development of technologies for the prevention, detection, diagnosis, monitoring, and treatment of cancer.

Common use cases include:

  • Artificial intelligence and bioinformatics

  • Therapeutics (drugs, biologics, cell therapies)

  • Diagnostics and medical devices

  • Manufacturing and biomanufacturing

  • Clinical validation and trials

  • Sample quality improvement and research tools

Which CPRIT Program is right for me?

CPRIT offers four programs designed for different stages and technology types:

SEED Awards (Earliest Stage)

  • Focus: Preclinical and company formation

  • Stage: Discovery → proof-of-concept

  • Goal: De-risk early science and make the company investable

  • Funding: Up to ~$3M

TDDC (Texas Diagnostic & Device Company Awards)

  • Focus: Diagnostics and medical devices

  • Stage: Late-stage development (near regulatory submission)

  • Goal: Advance toward commercialization and market entry

TTC (Texas Therapeutics Company Awards)

  • Focus: Therapeutics (drugs, biologics, cell therapies)

  • Stage: IND-enabling through clinical development

  • Goal: Advance clinical programs and regulatory approval

TNTC (Texas New Technologies Company Awards)

  • Focus: Emerging and non-traditional technologies

  • Stage: Varies

  • Examples: AI, platforms, research tools, enabling technologies

  • Goal: Support innovations that do not fit neatly into therapeutics or devices

What is the application process?

All CPRIT programs follow the same two-stage, competitive process:

Stage 1: Preliminary Application (Initial Screening)
Applicants submit:

  • Abstract

  • Executive summary (≤2 pages)

  • Slide deck (≤16 slides)

  • Project aims and budget

Applications are reviewed for scientific merit and alignment with CPRIT priorities. Only top applicants are invited to proceed.

Stage 2: Full Application (Deep Diligence)
Invited companies submit:

  • Integrated product development plan (technical, clinical, regulatory)

  • Full business plan (market, competition, commercialization, financials, IP)

  • Timeline and milestones

  • Management team and execution plan

Applicants present to an expert panel and undergo due diligence before final selection.

Final Decision Process

  • Scientific and product review

  • Due diligence

  • Program Integration Committee review

  • Final approval by CPRIT Oversight Committee

Funding is awarded via milestone-based contracts tied to performance.

What is the timeline to apply and when would I receive funding?

  • Preliminary Application Opens: April 7, 2026

  • Preliminary Application Deadline: April 16, 2026

  • Full Application Invitation: June 2026

  • Full Application Deadline: July 9, 2026

  • Award Period: September 1, 2026 – August 31, 2027

Funding is deployed over multiple years based on milestone completion.

Where does this funding come from?

Funding is provided by CPRIT through $6 billion in Texas taxpayer-backed general obligation bonds dedicated to cancer research and commercialization.

Who is eligible to apply?

Applicants must be:

  • Texas-based, for-profit companies (or willing to relocate)

  • Able to meet Texas presence requirements (e.g., HQ, personnel, manufacturing, or clinical activity in Texas)

  • Compliant with CPRIT eligibility rules

What companies and projects are likely to win?

  • Address a significant unmet medical need

  • Demonstrate strong technical validation

  • Show a clear path to commercialization

  • Have an experienced management team

  • Present a credible regulatory and development strategy

Are there any restrictions I should know about?

  • Must maintain a business presence in Texas or be willing to relocate to Texas upon selection for award

  • Matching funds are required

  • Indirect costs capped at ~5%

  • Travel expenses are not reimbursable (can count as matching funds)

  • Funding is milestone-based with reporting requirements

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  1. Triple your likelihood of success through proven strategy and insider-aligned proposal development

  2. Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  3. Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth.

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($20,000 + 5%) available (Only $5,000 for preliminary application).

Additional Resources

Review the solicitation here.

Read More
Active, Broad Topic Josiah Wegner Active, Broad Topic Josiah Wegner

NRL Long Range Broad Agency Announcement (BAA) for Basic and Applied Research - Naval Research Laboratory (NRL)

Deadline: Rolling through December 30th, 2026

Funding Award Size: Est. $500K to $5M

Description: Funding for basic and applied research across defense-critical areas including AI, materials, energy, cybersecurity, sensing, and space systems to advance U.S. Navy capabilities.

Updated October 2026: Amendment 0007 to the NRL Long Range BAA (N00173-24-S-BA01), issued September 30, 2026, extended white paper acceptance to December 30, 2026.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Naval Research Laboratory (NRL) is seeking innovative basic and applied research proposals across a wide range of scientific and engineering disciplines. Organizations can submit White Papers through September 30, 2026, with potential follow-on contracts, grants, or other agreements awarded based on technical merit. This solicitation now operates under ONR's newly released 2026 Science & Technology Strategy — known as "FEED at Speed" (Focus, Explain, Engage, Deploy, at Speed) — which reshapes how proposals will be evaluated and prioritized going forward.

How much funding would I receive?

Est. $500k to $5 million.

What's New: ONR's Strategic Priorities

ONR has signaled a sharper, more disciplined investment posture. Applicants should understand these shifts before submitting:

  • "Only ONR" Problems Take Priority. ONR is prioritizing challenges that are both highly transformational and uniquely naval — technology areas the commercial market won't invest in and that no one but ONR will develop. Proposals that read as incremental improvements or dual-use commercial plays (better suited to DIU or DONRCO) will face a tougher bar. Proposals should explicitly argue why this problem is uniquely a Navy/Marine Corps concern.

  • 11 S&T Focus Areas Now Anchor the Portfolio. All funded research should map cleanly to one (or more) of ONR's enduring Focus Areas:

    • Artificial Intelligence (AI) and Autonomy

    • Command, Control, Communications, Computers, Cyber, Intelligence, Surveillance, and Reconnaissance (C5ISR) and Naval Space

    • Directed Energy and Kinetic Systems

    • Materials and Electronics

    • Human and Biological Systems

    • Manufacturing

    • Naval Engineering

    • Naval Aerospace

    • Ocean, Atmosphere, and Space

    • Power and Energy

    • Undersea Systems

    Each Focus Area has subordinate Research Areas (63 total) — proposals should cite the specific Research Area(s) they align to, not just the broader Focus Area.

  • Transition Path Is Now a Scoring Factor, Not an Afterthought. ONR's new "Explain" pillar requires every funded program to articulate a credible transition path and map to specific "kill chain effects." Proposals that only describe scientific novelty without a Fleet/Force transition narrative will be weaker competitively. Strong proposals should address: How does this help the Warfighter win?

  • AI-Enabled Research Is Explicitly Encouraged. Under the "Speed" pillar, ONR is actively investing in research that uses AI to accelerate discovery itself (not just AI as a subject of study) — including AI-assisted hypothesis generation, automated experimentation, and AI-based validation/red-teaming of results. Proposals that incorporate AI-accelerated methodology into their research approach may align well with this emphasis.

  • Outcome-Based Metrics Replace Output-Based Metrics. ONR states it will now measure fielded capability and Warfighter impact rather than papers, prototypes, or activities completed. Proposals should define concrete, measurable outcomes tied to operational advantage, not just deliverables.

  • Small Business Programs (SBIR/STTR) Face New Scrutiny for Focus Area Alignment. ONR explicitly flagged SBIR/STTR and Manufacturing Technology programs for tighter alignment with the 11 Focus Areas — meaning off-taxonomy proposals may be deprioritized regardless of technical merit.

What could I use the funding for?

Funding supports basic and applied research aligned with Navy priorities, including (verbatim/high-level categories from the BAA):

  • Systems Directorate (e.g., radar, antennas, computational electromagnetics, information systems, AI/ML, human systems integration)

  • Materials Science and Component Technology (e.g., energy storage, corrosion, materials processing, bio/chemical detection)

  • Ocean and Atmospheric Science (e.g., ocean acoustics, remote sensing, environmental modeling)

  • Space Technology (e.g., spacecraft systems, sensors, propulsion, hypersonics)

Specific topic areas include (selected verbatim examples):

  • “Virtual simulations and mixed reality systems… situational awareness, and training”

  • “Data management and exploitation technologies that apply emerging mathematics and machine learning techniques”

  • “Multi-agent and multi-robot systems, reinforcement learning, game theory”

  • “Electrochemical energy storage and conversion systems such as batteries and fuel cells”

  • “Optical sciences… lasers, sensors, and photonic technologies”

  • “Cyber security, cryptographic technologies, and high assurance computing”

  • “Spacecraft payloads; spacecraft propulsion systems; advanced materials for spaceflight use”

Many More Topics are listed in the Solicitation (See below).

Are there any additional benefits I would receive?

Beyond the formal funding award, there are significant indirect benefits:

Government Validation and Credibility:
Being selected by the Naval Research Laboratory signals strong technical credibility and alignment with U.S. Navy and DoD priorities.

Access to Defense Ecosystem:
Awardees gain exposure to Navy researchers, program managers, and potential transition partners across defense and aerospace.

Flexible Contracting Pathways:
The BAA allows for multiple award mechanisms (contracts, grants, OTAs), enabling faster and more flexible engagement than traditional procurement.

Follow-On Funding Opportunities:
Successful projects may lead to additional funding phases or expanded research programs based on performance.

Increased Strategic Positioning:
Participation positions companies for future DoD funding, partnerships, and potential acquisition interest.

What is the timeline to apply and when would I receive funding?

  • White Papers Due: September 30, 2026 (4:00 PM EDT)

  • Rolling evaluation and invitation for full proposals after White Paper review

  • Funding timing varies based on evaluation and award negotiations

Where does this funding come from?

Department of Defense (DoD) → Department of the Navy → Office of Naval Research (ONR) → Naval Research Laboratory (NRL)

Who is eligible to apply?

  • Educational institutions

  • Small businesses

  • Small disadvantaged businesses

  • Historically Black Colleges and Universities (HBCUs)

  • Minority institutions

  • Other qualified organizations

What companies and projects are likely to win?

Selections are based on:

  • Technical merit and scientific quality of the proposed approach

  • Relevance to NRL research priorities

  • Potential benefit to the Government relative to cost

  • Feasibility and innovation of the solution

  • Cost realism and overall value

Are there any restrictions I should know about?

  • Must submit a White Paper first before a full proposal

  • Some topics may require security clearances or classified work

  • Awards depend on availability of funding

  • Government may select all, some, or none of proposals

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  1. Triple your likelihood of success through proven strategy and insider-aligned proposal development

  2. Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  3. Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth.

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($15,000 + 5%) available.

Additional Resources

Review the solicitation here.

Read More
Inactive, Broad Topic Josiah Wegner Inactive, Broad Topic Josiah Wegner

CDMRP: FY26 Epilepsy Research Program (ERP)

Deadline: Closed

Funding Award Size: $800k - $2m

Description: The FY26 Epilepsy Research Program (ERP) from CDMRP will fund research on post-traumatic epilepsy (PTE). Awards up to $2M are anticipated across multiple mechanisms.

Updated October 2026: This opportunity is closed. The FY26 application cycle for this program has closed. See our CDMRP guide for the next fiscal year’s announcements. Browse currently open opportunities in our funding database.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The FY26 Epilepsy Research Program (ERP) from the Congressionally Directed Medical Research Programs (CDMRP), managed by the Defense Health Agency Research and Development – Medical Research and Development Command, is expected to fund innovative research focused on post-traumatic epilepsy (PTE) and related comorbidities.

The program’s goal is to improve quality of life for Service Members, Veterans, caregivers, and the broader epilepsy community by advancing understanding of the biological mechanisms, epidemiology, progression, and treatment of PTE.

This announcement is a pre-announcement, meaning investigators should begin preparing ideas now. Application deadlines have not yet been released. The official Funding Opportunity Announcements (FOAs), which will include submission deadlines, will be posted on Grants.gov.

How much funding would I receive?

Funding amounts depend on the award mechanism.

  • Idea Development Award

    • Maximum funding: $1 million total costs

    • Maximum period of performance: 3 years

  • Leveraging Research Award

    • Maximum funding: $800,000 total costs

    • Maximum period of performance: 3 years

  • Research Partnership Award

    • Maximum funding: $2 million total costs

    • Maximum period of performance: 3 years

  • Virtual Post-Traumatic Epilepsy Research Center – Leadership Award

    • Maximum funding: $1.6 million total costs

    • Maximum period of performance: 4 years

  • Virtual Post-Traumatic Epilepsy Research Center – Faculty Award

    • Maximum funding: $800,000 total costs

    • Maximum period of performance: 3 years

Total costs include direct and indirect costs.

What could I use the funding for?

ERP funding supports research designed to advance understanding of post-traumatic epilepsy (PTE) and related conditions. Applications should address at least one of the program’s focus areas:

Markers and Mechanisms of PTE

  • Identification of biomarkers predicting epilepsy development

  • Research into biological mechanisms that could prevent epileptogenesis or seizure activity

Epidemiological Characterization of PTE

  • Identifying predictors of epilepsy development

  • Studying patient outcomes such as latency to epilepsy onset, comorbidities, and mortality

  • Measuring impacts on quality of life for patients and caregivers

Longitudinal Studies of PTE Progression

  • Tracking disease progression over time

  • Evaluating treatment outcomes and quality of care

  • Studying interactions between epilepsy and comorbid conditions such as psychiatric disorders, cognitive deficits, sleep disorders, and fatigue

Innovative Research Tools and Technologies

  • Artificial intelligence or bioinformatics tools

  • Clinical databases and advanced device technologies for seizure detection and diagnosis

  • Models for studying post-traumatic epilepsy

  • Tools enabling future clinical trials

Are there any additional benefits I would receive?

Some award mechanisms provide benefits beyond funding.

For example:

  • Research Partnership Award

    • Supports collaborative research between two named Principal Investigators

  • Virtual Post-Traumatic Epilepsy Research Center – Leadership Award

    • Provides funding to lead a virtual research center

    • Includes responsibilities such as mentoring investigators and facilitating collaboration

  • Virtual Post-Traumatic Epilepsy Research Center – Faculty Award

    • Supports early-career researchers or investigators new to the PTE field

    • Includes mentorship and career development within a collaborative research environment

What is the timeline to apply and when would I receive funding?

The process will include:

  • Pre-application submission through eBRAP

  • Pre-applications will be Letters of Intent

  • Full applications will follow the requirements outlined in the final FOAs on Grants.gov

Where does this funding come from?

Funding comes from the FY26 Defense Appropriations Act, which provides funding for the Epilepsy Research Program (ERP).

The program is administered by:

  • Congressionally Directed Medical Research Programs (CDMRP)

  • Defense Health Agency Research and Development – Medical Research and Development Command

ERP focuses on research that benefits Service Members, Veterans, caregivers, and the broader epilepsy community.

Who is eligible to apply?

Eligibility depends on the award mechanism:

  • Idea Development Award

    • Independent investigators at any career level may serve as Principal Investigator

  • Leveraging Research Award

    • Independent investigators at any career level may serve as Principal Investigator

  • Research Partnership Award

    • Two named Principal Investigators who are independent investigators at any career level

  • Virtual P-TERC Leadership Award

    • Director and Deputy Director must be independent investigators with:

      • Strong history of PTE research funding

      • Peer-reviewed publications

      • Mentorship experience

  • Virtual P-TERC Faculty Award

    • Early-career investigators or investigators new to the PTE field

What companies and projects are likely to win?

ERP prioritizes research that:

  • Advances understanding of post-traumatic epilepsy and associated comorbidities

  • Improves quality of life for Service Members, Veterans, and caregivers

  • Demonstrates innovation or high creativity

  • Challenges existing research paradigms

  • Leverages existing datasets, cohorts, or research infrastructure

  • Includes strong collaborations where appropriate

Are there any restrictions I should know about?

Key requirements include:

  • Pre-applications must be submitted through eBRAP

  • All pre-applications are Letters of Intent

  • Full applications must follow the requirements of the final Funding Opportunity Announcements on Grants.gov

  • Applications must align with the ERP’s focus areas on post-traumatic epilepsy

How long will it take me to prepare an application?

Preparation time will depend on the complexity of the project and research team.

Typical CDMRP submissions involve:

  • A Letter of Intent (pre-application)

  • A full application including research plan, budget, and supporting documentation

Because official deadlines have not yet been released, investigators should begin developing project concepts now so they are ready once the FOAs are posted.

How can BW&CO help?

BW&CO supports companies and research teams pursuing CDMRP and other federal research funding by:

  • Identifying the most competitive award mechanism

  • Developing a compelling proposal narrative aligned with program priorities

  • Structuring the research plan and milestones

  • Coordinating multi-institution collaborations

  • Managing the full submission process through eBRAP and Grants.gov

Our team has extensive experience helping applicants pursue defense health and biomedical research funding.

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.

Additional Resources

Review the solicitation here.

Read More
Inactive, Broad Topic Josiah Wegner Inactive, Broad Topic Josiah Wegner

CDMRP: FY26 Alzheimer’s Research Program (AZRP)

Deadline: Closed

Funding Award Size: $1m-$1.8m

Description: The FY26 DoD Alzheimer’s Research Program (AZRP) offers up to $1.8M for research improving dementia care, diagnosis, and risk reduction. Preproposal required; full application by invitation only.

Updated October 2026: This opportunity is closed. The FY26 application cycle for this program has closed. See our CDMRP guide for the next fiscal year’s announcements. Browse currently open opportunities in our funding database.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Fiscal Year 2026 (FY26) Alzheimer’s Research Program (AZRP) is expected to release funding opportunities through the Congressionally Directed Medical Research Programs (CDMRP) to support impactful research addressing Alzheimer’s disease and Alzheimer’s disease–related dementias (AD/ADRD).

06-22-2026 - (Pre-application - Pre-Proposal)
09-24-2026 - (Application)

The program’s mission is to fund solution-oriented research that improves quality of life for people living with Alzheimer’s disease and related dementias, including Service Members, Veterans, their Families, and the general public.

Congress appropriated $15.0 million for the FY26 Alzheimer’s Research Program.

The FY26 AZRP is expected to support research that improves diagnosis, prevention, risk reduction, and quality of life for individuals affected by AD/ADRD.

How much funding would I receive?

Funding depends on the award mechanism.

Transforming Care Award

  • Maximum funding: $1.6M total costs

  • Maximum period of performance: 4 years

Career Initiation or Transition Partnership Option (CITPO):

  • Maximum funding: $1.8M total costs

  • Maximum period of performance: 4 years

Transforming Diagnosis Award

  • Maximum funding: $1.5M total costs

  • Maximum period of performance: 4 years

Career Initiation or Transition Partnership Option (CITPO):

  • Maximum funding: $1.7M total costs

  • Maximum period of performance: 4 years

Transforming Research Award

  • Maximum funding: $1M total costs

  • Maximum period of performance: 3 years

What could I use the funding for?

Funding supports non-incremental, solution-focused research addressing Alzheimer’s disease and related dementias (AD/ADRD).

The allowable research depends on the mechanism.

Transforming Care Award

Supports well-designed non-incremental clinical research or clinical trials in dementia care that provide solutions for individuals living with AD/ADRD.

Projects may address:

  • Care interventions

  • Strategies or technologies for dementia care

  • Tools that improve daily living and support systems

  • Approaches that reduce caregiver burden and stress

  • Methods that improve quality of life for individuals with dementia

Applications are encouraged to prioritize both:

  • Individuals living with AD/ADRD

  • Their care partners

Transforming Diagnosis Award

Supports solutions-oriented research addressing barriers to diagnosis, disease monitoring, or prognosis.

Barriers may include:

  • Diagnostic technologies

  • Cost barriers

  • Access to diagnostic tools

  • Clinical implementation challenges

  • Biomarker validation

  • Disease monitoring methods

  • Lack of longitudinal data for prediction or prognosis

Research may include:

  • Prospective human subject recruitment

  • De-identified human samples, specimens, or datasets

Transforming Research Award

Supports research that reduces risk and prevents the development of AD/ADRD.

Applications must address one of two focus areas:

Risk factor knowledge

  • Identification or validation of risk or protective factors

  • Environmental, epigenetic, genetic, lifestyle, or occupational risks

Risk reduction solutions

  • Non-pharmacological methods

  • Technologies

  • Prevention strategies that reduce risk of AD/ADRD

The program encourages studies leveraging existing cohorts or datasets, including cohorts 65 years or younger.

Are there any additional benefits I would receive?

The pre-announcement does not specify additional non-funding benefits.

However, CDMRP programs typically provide:

  • Access to a two-tier review system combining scientific peer review and programmatic review to ensure scientific merit and mission relevance.

  • Opportunities to collaborate with researchers, clinicians, and community stakeholders affected by the disease.

What is the timeline to apply and when would I receive funding?

06-22-2026 - (Pre-application - Pre-Proposal)
09-24-2026 - (Application)

Where does this funding come from?

This funding comes from the Congressionally Directed Medical Research Programs (CDMRP) within the Department of Defense.

Key facts:

  • Funding was appropriated through the Consolidated Appropriations Act, 2026.

  • CDMRP manages biomedical research programs supporting the health of Service Members, Veterans, their Families, and the American public.

Who is eligible to apply?

Detailed eligibility criteria will be provided in the official Funding Opportunity Announcements.

What companies and projects are likely to win?

The AZRP supports projects that:

  • Address critical needs in Alzheimer’s disease and related dementias

  • Deliver solution-oriented outcomes

  • Improve diagnosis, prevention, or patient quality of life

  • Demonstrate clear relevance to Service Members, Veterans, their Families, or the broader public

Projects that show strong scientific merit and mission relevance are prioritized through CDMRP’s two-tier review process.

Are there any restrictions I should know about?

Restrictions and requirements are not specified in the pre-announcement.

These details—including allowable costs, research scope limitations, and regulatory requirements—will be defined in the full Funding Opportunity Announcements.

How long will it take me to prepare an application?

The preparation timeline is not specified in the pre-announcement.

CDMRP programs often use a two-stage process that may include:

  • Pre-application submission

  • Invitation to submit a full application

However, the specific process for FY26 AZRP is not specified in the pre-announcement.

How can BW&CO help?

BW&CO supports teams pursuing CDMRP funding by:

  • Assessing project fit with the AZRP mission and research priorities

  • Developing a competitive technical narrative

  • Structuring proposals to align with CDMRP review criteria

  • Managing submission strategy, compliance, and timeline

  • Coordinating collaborators, investigators, and supporting documentation

Our team has extensive experience supporting Department of Defense CDMRP grant applications.

Additional Resources

Review the solicitation here.

Read More
Broad Topic, Active Josiah Wegner Broad Topic, Active Josiah Wegner

CDMRP: FY26 Autism Research Program

Deadline: July 27, 2026 (pre-application), October 22, 2026 (full application)

Funding Award Size: $750-$1.75m

Description: The FY26 Autism Research Program (ARP) from the Department of Defense will fund autism research projects with awards up to $1.75M. Multiple mechanisms support early-career investigators, clinical trials, and innovative research ideas. Pre-application required through eBRAP.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Fiscal Year 2026 (FY26) Autism Research Program (ARP) from the Congressionally Directed Medical Research Programs (CDMRP) will fund innovative, high-impact research with clinical relevance that improves outcomes for individuals with autism and their families. The program released this pre-announcement to allow investigators time to plan proposals before the formal Funding Opportunity Announcements (FOAs) are released.

The FY26 ARP was funded through the FY26 Defense Appropriations Act. Investigators should begin preparing now because the program will require a pre-application before submission of a full proposal once the FOAs are released.

Application deadline: The deadline is not specified in the solicitation. Deadlines will be published in the FY26 ARP funding opportunity announcements when they are released on Grants.gov.

How much funding would I receive?

Funding depends on the specific award mechanism.

Career Development Award

  • Maximum funding: $750,000 total costs

  • Maximum period of performance: 3 years

Clinical Trial Award

  • Maximum funding: $1.5 million total costs

  • Maximum period of performance: 4 years

Clinical Trial Award – Nested Early-Career Investigator Option

  • Maximum funding: $1.75 million total costs

  • Maximum period of performance: 4 years

Idea Development Award

  • Maximum funding: $750,000 total costs

  • Maximum period of performance: 3 years

Total costs include direct and indirect costs.

What could I use the funding for?

Each mechanism supports different types of autism research.

Career Development Award

  • Supports early-career independent investigators or established investigators transitioning into autism research.

  • Projects must pursue research with the potential to have a major impact on autism.

  • Supported activities include:

    • Innovative, high-impact research ideas

    • Early-phase, proof-of-principle clinical trials

  • Preliminary data is required.

Clinical Trial Award

  • Supports research with the potential to have a major impact on the treatment and/or management of autism.

  • Projects must involve clinical trials supported by preliminary data.

Clinical Trial Award – Nested Early-Career Investigator Option

  • Allows a senior investigator (initiating PI) to collaborate with a young investigator.

  • Supports the development of investigators pursuing careers in autism clinical trial research.

Idea Development Award

  • Supports innovative, high-impact ideas that advance understanding of autism and lead to improved outcomes.

  • Includes a Partnering PI Option allowing collaboration between two investigators.

  • Clinical trials are not allowed under this mechanism.

All mechanisms require preliminary data relevant to the proposed project.

Are there any additional benefits I would receive?

The program includes several structural benefits:

  • Career Development Award supports the transition of researchers into the autism field.

  • Clinical Trial Award – Nested Early-Career Investigator Option provides structured development for young investigators.

  • Idea Development Award – Partnering PI Option encourages collaboration between investigators.

These structures are designed to expand the autism research workforce and accelerate impactful research.

What is the timeline to apply and when would I receive funding?

  • Pre-announcement released: March 2, 2026

  • Funding Opportunity Announcements (FOAs) will be posted on Grants.gov.

  • Pre-application submission through eBRAP is required before submitting a full application.

  • Application submission is by invitation only after review of the pre-application.

  • Pre-application and full application deadlines are not specified in the pre-announcement.

  • Funding start dates are not specified in the pre-announcement.

Where does this funding come from?

Funding for the program comes from the FY26 Defense Appropriations Act and is administered by the Congressionally Directed Medical Research Programs (CDMRP) within the Defense Health Agency Research and Development – Medical Research and Development Command.

The program is part of the Department of Defense’s Autism Research Program (ARP).

Who is eligible to apply?

Eligibility varies by mechanism.

Career Development Award
Applicants must:

  • Be independent investigators at or below the level of Assistant Professor, or equivalent,

    or

  • Be established investigators in a field other than autism at or above the level of Assistant Professor seeking to transition into autism research.

Additional requirements:

  • Must not have previously received a Career Development Award (or equivalent) from any CDMRP program or other federal agency.

  • Must not have received more than $250,000 in total direct costs for previous or concurrent autism research as a PI of federally or privately funded non-mentored peer-reviewed grants.

  • Must hold a Ph.D., M.D., M.D./Ph.D., or equivalent at the time of pre-application submission.

  • Must not be a graduate student, postdoctoral fellow, or other mentored researcher.

Clinical Trial Award

  • Independent investigators at any career level.

Clinical Trial Award – Nested Early-Career Investigator Option
Young investigator must:

  • Be currently in postdoctoral training or have completed postdoctoral training.

  • Be no more than 7 years from receipt of a terminal degree.

  • Commit at least 50% time to the project.

Idea Development Award

  • Independent investigators at any career level.

What companies and projects are likely to win?

Based on the pre-announcement, competitive applications will likely:

  • Propose innovative, high-impact research addressing autism

  • Demonstrate strong preliminary data

  • Show potential for major impact on understanding, treatment, or management of autism

  • Align with the goals of the specific award mechanism

  • For collaboration options, demonstrate meaningful partnerships between investigators

Applications must clearly demonstrate scientific merit and potential impact.

Are there any restrictions I should know about?

Key restrictions include:

  • Pre-application submission through eBRAP is required before submitting a full application.

  • Full applications are submitted by invitation only.

  • Preliminary data is required for all mechanisms.

  • Idea Development Award applications cannot support clinical trials, including a clinical trial aim.

  • Career Development Award applicants must meet prior funding and career stage restrictions.

All applications must conform to the final Funding Opportunity Announcements posted on Grants.gov.

How long will it take me to prepare an application?

The solicitation does not specify preparation time.

However, because the ARP uses a two-stage process (pre-application followed by invitation-only full application), applicants typically need time to:

  • Prepare a competitive pre-proposal

  • Develop preliminary data and a detailed research plan

  • Assemble collaborators and institutional approvals

Investigators are encouraged to begin planning early before FOAs are released.

How can BW&CO help?

BW&CO can support applicants throughout the ARP application process, including:

  • Evaluating project fit with ARP mechanisms

  • Developing a competitive proposal strategy

  • Structuring impact-focused research narratives

  • Managing the pre-application and full application process

  • Preparing supporting documents and compliance materials

  • Coordinating multi-investigator collaborations

Our team has extensive experience supporting Department of Defense CDMRP grant applications.

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.

Additional Resources

Review the solicitation here.

Read More
Active, Broad Topic Josiah Wegner Active, Broad Topic Josiah Wegner

Installation Energy & Water - Environmental Security Technology Certification Program (ESTCP)

Deadline: Rolling through August 20th, 2027

Funding Award Size: $300K to $5M+

Description: Funding for demonstration and validation of mature energy, water, cybersecurity, and building technologies that improve resilience, efficiency, and mission assurance at DoD installations.

Updated October 2026: ESTCP posted a new Open Topics BAA (W912HQ26S0051) on August 21, 2026 that includes Installation Energy and Water. White papers are accepted through August 20, 2027.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Environmental Security Technology Certification Program (ESTCP) is soliciting pre-proposals for FY 2027 to fund formal demonstrations of innovative Installation Energy & Water technologies. ESTCP supports mature technologies that improve energy resilience, water resilience, cybersecurity, and building performance at DoD installations through real-world demonstrations conducted at DoD facilities. Pre-proposals are due March 26, 2026 at 2:00 p.m. ET.

How much funding would I receive?

ESTCP awards typically support multi-year demonstration projects funded through cost-type or firm fixed-price contracts. While individual award sizes are not specified in the solicitation, projects commonly range from hundreds of thousands to several million dollars, depending on scope, duration, and demonstration scale.

What could I use the funding for?

Funding may be used to demonstrate and validate innovative technologies in one of the following ESTCP FY 2027 Installation Energy & Water Topic Areas:

Improve Energy Resilience with Long-Duration Energy Storage
This topic area seeks demonstrations of Long Duration Energy Storage (LDES) technologies integrated into military microgrids to meet the DoD’s requirement to power critical loads for 14 days during a grid outage. Technologies of interest include electrochemical, chemical, thermal, subsurface, and other LDES approaches, evaluated through Hardware-in-the-Loop (HIL) testing. The focus is on reducing or eliminating reliance on diesel fuel while improving lifecycle cost-effectiveness, resilience, and cybersecurity of installation microgrids.
Read more here.

Improving the Cyber Resilience of DoW Installation Energy Systems
This topic focuses on closing critical cybersecurity gaps in Facility-Related Control Systems (FRCS) that support energy and water infrastructure. ESTCP is seeking demonstrations of novel solutions that improve secure connectivity, threat detection, and cyber defense at machine speed, including alternatives to fiber connectivity, high-fidelity honeypots, and AI-driven defensive cyber agents. The goal is to reduce the risk of cyber-physical disruption to mission-critical installation systems without requiring major infrastructure modifications.
Read more here.

Improving the Energy Resilience of DoW Installations
This topic area solicits technologies that enhance the ability of military installations to continue mission-critical operations during energy disruptions. Solutions may include hardware, software, planning tools, infrastructure hardening, or integrated energy-water-control approaches, but exclude LDES-only solutions, which must submit under the LDES topic. Technologies should reduce dependence on imported energy, address regional challenges (e.g., arctic, remote, or arid locations), and demonstrate scalability across multiple installations.
Read more here.

Solutions to Improve Energy Efficiency and Performance of DoW Buildings
This topic seeks demonstrations of innovative retrofit-ready technologies that reduce energy use intensity, lower maintenance burden, improve occupant health, and decrease lifecycle costs in DoD buildings. Technologies of interest include HVAC, building envelope systems, lighting, water heating, waste heat recovery, and integrated control solutions. ESTCP prioritizes solutions that work with existing infrastructure, deliver measurable energy savings, and have a clear pathway to adoption through ESCOs, ESPCs, or utility programs.
Read more here.

Water Resilience on DoW Installations
This topic area focuses on technologies and methodologies that improve the reliability, security, and efficiency of water systems supporting military missions. Areas of interest include potable water reduction, water storage (minimum 8,000 gallons), desalination improvements, leak detection, corrosion-resistant materials, building-scale water reuse, and advanced water monitoring. Solutions should reduce operational burden, address water-stressed regions, and support long-term resilience of aging installation water infrastructure.
Read more here.

Are there any additional benefits I would receive?

Beyond the direct funding award, ESTCP provides significant strategic advantages:

  • DoD Validation and Credibility: ESTCP selection signals that your technology meets high-priority DoD installation needs and has passed rigorous technical review.

  • Accelerated Adoption Pathways: Demonstrations are explicitly designed to support transition, regulatory acceptance, and scaling across multiple DoD installations.

  • Non-Dilutive Growth: ESTCP funding allows companies to mature and validate technology without giving up equity, strengthening long-term enterprise value.

  • Visibility with Defense Stakeholders: Successful projects are published, presented, and shared across DoD, regulatory, and industry communities—raising profile and credibility.

What is the timeline to apply and when would I receive funding?

  • Pre-Proposals Due: March 26, 2026 (2:00 p.m. ET)

  • Full Proposal Invitations: May 2026

  • Full Proposals Due: July 2026

  • Technical Committee Briefings: August 2026

  • Project Selection: September 2026

  • Anticipated Contract Awards: Q3 FY 2027.

Where does this funding come from?

Funding is provided by the Environmental Security Technology Certification Program (ESTCP) under the Office of the Deputy Assistant Secretary of Defense (Energy Resilience & Optimization) within the U.S. Department of Defense.

Who is eligible to apply?

Eligibility depends on organization type:

  • Private industry and universities: Apply under the FY27 ESTCP Broad Agency Announcement (BAA)

  • DoD organizations: Apply under the FY27 DoD Call for Proposals

  • Other Federal agencies: Apply under the FY27 Federal Call for Proposals

All proposers must submit a pre-proposal and respond to an eligible Topic Area.

What companies and projects are likely to win?

Successful proposals typically:

  • Address a clearly defined, enterprise-wide DoD installation need

  • Demonstrate technologies at TRL or ARL 5–7

  • Provide strong cost, performance, and risk-reduction benefits

  • Include a clear DoD end user and transition pathway

  • Are scalable across multiple installations and Services

Are there any restrictions I should know about?

Projects will not be considered responsive if they:

  • Are already broadly deployed across the DoD enterprise

  • Require access to large volumes of high-quality DoD data

  • Solve a problem unique to a single installation

  • Represent basic research or early-stage exploratory development

How long will it take me to prepare an application?

For first time applicants, pre-proposals will likely take 35 to 50 hours with assistance.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

Review the solicitation here.

Read More
Broad Topic, Active Josiah Wegner Broad Topic, Active Josiah Wegner

Science & Technology Long Range Broad Agency Announcement (LRBAA 24-01) – Department of Homeland Security

Deadline: Rolling until May 31, 2029

Funding Award Size: Est. $500K to $5 million

Description: Funding for scientific and technical research that enhances homeland security capabilities across DHS operational environments and mission areas.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) is funding scientific and technical research projects that significantly improve or increase capabilities across the Homeland Security Enterprise. This Long Range Broad Agency Announcement (LRBAA 24-01) supports near-term operational needs, foundational science, and future/emerging threat research through contracts, grants, cooperative agreements, and Other Transaction Agreements (OTAs). Apply before funds are fully utilized.

How much funding would I receive?

Est. $500K to $5 million. The LRBAA does not specify minimum or maximum award sizes. Funding amounts depend on the technical merit of the proposal, relevance to DHS mission needs, and availability of funds. DHS may fund all, some, or none of the proposals received, and multiple awards are anticipated

What could I use the funding for?

Funding under this LRBAA may be used for research, development, test, and evaluation (RDT&E) activities aligned with DHS Science & Technology Directorate mission needs. DHS is currently seeking projects across the following priority research topic areas. See full topic descriptions here.

Counter Terrorism and Homeland Security Threats (CTHOM)
DHS S&T works to identify individuals or groups that intend to conduct terrorist attacks and/or illicitly move weapons, dangerous goods, and contraband. It also provides assessments of high-consequence attack methods such as CBE threats that terrorists may use to attack the United States.

CTHOM 01: Development of Tools for Test and Evaluation of Machine Learning Algorithms
DHS S&T seeks development of cost-effective methodologies and tools for training and testing of Machine Learning-based (ML-based) algorithms for detecting explosives and contraband in Computed Tomography (CT) and Millimeter Wave (MMW) images. This includes methods to synthesize training and testing data, methods to perturb empirical data in order to explore and explain algorithm performance characteristics, and tools to assess the completeness and diversity of training and test data sets.

CTHOM 03: Novel Approaches and Locations for Explosive Performance Characterization and Testing
Enabling research for the characterization and testing of explosives poses a unique challenge for threat characterization. Innovative tools and methods are needed to provide improvements in evaluating legacy approaches to characterization, adapting state-of-the-art technologies in related disciplines, and integrating emerging innovations.

Secure U.S. Borders and Approaches (BORAP)
DHS secures U.S. borders, territorial waters, ports, terminals, waterways, and air, land, and sea transportation systems. DHS S&T invests in border security research and development for technologies and solutions to prevent illicit movement and the illegal entry or exit of people, weapons, dangerous goods, and contraband.

BORAP 01: Screening at Speed
Screening at Speed seeks to mature transformative technologies that increase aviation security effectiveness from curb-to-gate while dramatically reducing wait times and improving passenger experiences.

BORAP 04: Countering Unmanned Aircraft Systems
The primary objective of this LRBAA is to develop enhanced technologies and methods that allow for the detection, tracking, identification, and mitigation of unmanned aircraft systems under varied terrains and environmental conditions such as dense urban environments, mass gatherings, critical infrastructure, mobile platforms, and remote terrain.

BORAP 07: Detection Canine Technologies
Detection Canine development interests are focused on canine research and development structure and function, development and testing of canine training aids, and independent operational test and evaluation to advance detection canine performance in operational environments.

Secure Cyberspace and Critical Infrastructure (CYBCI)
Protecting individuals and organizations from cyber attacks requires RDT&E, test and evaluation, and the technology transition of advanced cybersecurity and information assurance solutions to secure current and future critical cyber infrastructure.

CYBCI 02: Shared Cyber Resilience
The research and development of improved models of resilience across networked hardware and software systems and organizations, including automated cyber attack mitigation, resilient machine learning approaches, privacy preservation techniques, secure multi-party computing, and human-machine teaming for cybersecurity.

CYBCI 03: Software and Hardware Supply Chain Assurance
The research and development of tools and techniques to ensure the resilience of the data, software, and hardware used to execute homeland security mission functions, including post-quantum cryptography, secure-by-design architectures, microelectronics, IoT, cloud and edge computing, and DevSecOps supply-chain assurance techniques.

CYBCI 04: Trustworthy and Responsible Artificial Intelligence
Research and development to enable DHS to effectively assess AI/ML systems against technical and mission metrics, provide operators an appropriate level of trust and confidence, and inspire trust in the general public toward AI/ML systems deployed by DHS.

CYBCI 05: Advanced and Emerging Data Computation and Analytics
This topic focuses on novel computational and analytic methods and capabilities for large-scale data sets for DHS missions, including real-time analytics, privacy-enhancing technologies, high-performance computing, digital twins, synthetic data, and advanced analytics to improve mission effectiveness and efficiency.

Are there any additional benefits I would receive?

Beyond the direct funding, LRBAA awards provide several indirect advantages:

  • Government Validation and Credibility: Selection signals strong technical merit and alignment with DHS mission priorities.

  • Pathway to Transition and Deployment: Projects are designed to support operational relevance and transition to DHS components.

  • Access to DHS Test and Evaluation Infrastructure: DHS may provide access to government laboratories and operational test facilities where appropriate.

  • Stronger Long-Term Commercial and Contracting Potential: DHS-funded R&D can increase credibility with future government customers and partners.

What is the timeline to apply and when would I receive funding?

This LRBAA is open through May 31, 2029 at 11:59 PM ET. Companies should apply as soon as possible while funds are available. Submissions follow a three-step process:

  1. Industry Engagement Submission (initial research concept)

  2. Virtual Pitch (by invitation only)

  3. Written Proposal (by invitation only)

Typical DHS response timelines (subject to change):

  • Industry Engagement feedback: ~10 business days

  • Virtual Pitch evaluation: ~21 business days

  • Written Proposal evaluation: ~21 business days

Award timing depends on evaluation outcomes and funding availability.

Where does this funding come from?

Funding is provided by the Department of Homeland Security Science and Technology Directorate (DHS S&T) through the Office of Procurement Operations.

Who is eligible to apply?

Eligible applicants include:

  • U.S. small businesses and large businesses

  • Academic institutions

  • Government laboratories and Federally Funded Research and Development Centers (FFRDCs)

  • Nonprofits and research organizations

Foreign or foreign-owned entities may participate but are subject to export control, foreign disclosure, and other federal review requirements. There are no set-asides, but DHS strongly encourages small business participation.

What companies and projects are likely to win?

Proposals are evaluated based on:

  • Alignment with DHS mission needs and topic relevance

  • Scientific and technical merit of the proposed approach

  • Degree of innovation and potential capability improvement

  • Operational relevance and transition potential

  • Reasonableness of cost and feasibility of execution

Are there any restrictions I should know about?

Key restrictions include:

  • Proposal preparation costs are not reimbursable

  • Only unclassified materials may be submitted

  • Mature commercial products and support services are not eligible

  • Participation in later proposal stages is invitation-only

  • Export control, IP, and data rights requirements apply

How long will it take me to prepare an application?

Without BW&CO’s assistance the Industry Engagement submission would typically take 35-50 hours.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for a flat fee of $4,000 for the Industry Engagement Submission.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

Review the solicitation here.

Read More
Inactive, Broad Topic Josiah Wegner Inactive, Broad Topic Josiah Wegner

Agriculture and Food Research Initiative (AFRI): Strengthening Agricultural Systems – USDA NIFA

Deadline: Closed

Funding Award Size: $1 Million to $10 Million

Description: Funding for large-scale, integrated research, education, and extension projects that strengthen U.S. agricultural systems, expand markets, combat pests and diseases, improve nutrition and health outcomes, and enhance farmer prosperity.

Updated October 2026: This opportunity is closed. The FY26 NOFO closed in April 2026. No FY27 NOFO has been posted yet. Browse currently open opportunities in our funding database.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The USDA National Institute of Food and Agriculture (NIFA) is awarding up to $10 million per project through the Agriculture and Food Research Initiative (AFRI) Strengthening Agricultural Systems (SAS) program to support large-scale, integrated research, education, and extension projects that transform U.S. food and agricultural systems, increase agricultural production, and enhance farmer prosperity. Applications are due March 26, 2026 (or April 23, 2026 for the AI for K-12 priority).

How much funding is available?

Awards range from $1 million to $10 million per project, with total anticipated FY 2026 program funding of approximately $140 million. Grant durations may be up to 60 months.

What could I use the funding for?

See a detailed description here.

New Uses and Expanding Markets for Agriculture and Forestry Products Sub-priority:

Proposals should focus on the most pressing challenges faced by agricultural producers, farmers, ranchers, and foresters with a focus on creating new and expanding existing markets for agriculture and forestry products to ensure a strong U.S. economy and protect the fuel and fiber supply. Proposals responding to this sub-priority must address items a) and b). Proposals may also address item c) below:

a) Work with established U.S. commodity crops, specialty crops, or forest products that develop new uses for crop residues for meal, feed, or oils will be considered. Pursuit of this goal depends on the development of new innovative solutions and initiatives that bring more jobs, economic opportunities, and expand existing markets to new regions particularly to rural communities. The focus should be on equipping and empowering current and next generations of American farmers, ranchers, producers, and foresters; and

b) Address the long-term efforts necessary for growth of agriculture and/or forestry products markets while preserving our nation’s natural resources through conservation, restored forests, improved watersheds, and healthy private working lands.

c) May also address: Develop or enhance systems to produce reliable sources of biofuels, biomaterials, or biobased chemical intermediates, including emphasis on high-value or value-added products from agricultural and/or forestry products to foster rural prosperity and enhance national security.

Solutions to Pests and Diseases of Plants or Animals Sub-priority:

Proposals responding to this sub-priority must address at least two (2) of the following:

a) Protect the food, fuel, and/or fiber supply as well as enhance national security by developing innovative solutions to combat pests, diseases, or weeds (invasive/established species) negatively affecting plant and/or animal agricultural systems.

b) Address important crop, livestock, or forest losses due to pest and/or pathogen damage.

c) Develop effective disease or pest solutions, including weed management solutions in grasslands/rangelands, as they occupy a substantial portion of the United States and impact both plant and animal production and are critical to the nation’s economy.

d) Drive innovation, promote proven agricultural or forest production practices, reduce input costs, and increase outputs that result in maximizing productivity of American farmers, ranchers, and foresters.

Combating Food and Diet-Related Chronic Diseases Sub-priority:

Proposals responding to this sub-priority must address item a) or item b). Proposals must also address at least two (2) of the following items: c), d), and/or e):

a) Address factors linked to achieving healthy diets from sustainable food production systems with the goal of increasing nutrient content and bioavailability of nutrients from plant and/or animal food products to improve human health.

b) Identify and implement innovative solutions that result in healthy dietary patterns, support the Dietary Guidelines for Americans, and lead to long-term large population-level reductions of diet-related chronic diseases.

c) Upscale or maximize impacts of existing scientifically proven interventions/solutions.

d) Incorporate stakeholders’ perspectives, particularly American farmers’ or ranchers’ voices as they play a critical role in ensuring an abundant, healthy and safe food supply.

e) Explore value-add solutions that benefit agricultural producers, farmers, ranchers, or foresters.

Artificial Intelligence for K-12 Food and Agricultural Sciences:

Proposals responding to this priority must address at least four (4) of the following:

a) Develop and/or strengthen the pipeline of AI-literate and skilled next-generation agriculturalists, with special emphasis in K-12 youth, to support the advancements in food, agricultural, and forest sciences.

b) Adapt or develop AI-based tools and modalities that can be effectively integrated into classrooms, non-formal educational experiences, and/or curriculums to support the understanding and training of the next generation of agriculturalists and foresters.

c) Build and expand comprehensive teacher and non-formal educator training in AI in food, agricultural, and/or forest sciences to equip them with knowledge to train students about AI and to utilize AI in their classrooms to improve educational outcomes.

d) Support AI resource sharing mechanisms that make curriculum, training materials and courses, and resources accessible for the nation’s K-12 teachers and Cooperative Extension educators in food and agricultural sciences.

e) Equip learners to become future innovators of agricultural AI.

f) Advance the scientific, economic, environmental, social, and/or workforce training innovations in food, agriculture, and/or forestry to keep U.S. farmers, ranchers, producers, and foresters at the forefront of productivity by leveraging AI.

g) Use AI to help strengthen youth’s understanding of the importance of America’s food, fuel, and fiber supply and its role in national security.

Are there any additional benefits I would receive?

Beyond the funding itself, AFRI SAS awards provide substantial indirect value. Selection by USDA-NIFA signals strong technical merit and national relevance, which can enhance credibility with partners, stakeholders, and future funders. Awardees gain visibility within the federal agricultural innovation ecosystem and may benefit from collaboration opportunities across universities, industry, government, and extension networks. Long-term, this type of nondilutive funding can strengthen institutional capacity and position organizations for future large-scale federal awards.

What is the timeline to apply and when would I receive funding?

  • Letter of Intent (optional): February 26, 2026

  • Application Deadline:

    • March 26, 2026 (Strengthening Agricultural Systems)

    • April 23, 2026 (AI for K-12 Food and Agricultural Sciences)

Awards are expected to be made within the FY 2026 federal fiscal year, with project start dates no later than September 30, 2026, subject to appropriations.

Where does this funding come from?

Funding is provided by the U.S. Department of Agriculture (USDA) through the National Institute of Food and Agriculture (NIFA) under the Agriculture and Food Research Initiative (AFRI), Assistance Listing 10.310.

Who is eligible to apply?

Eligible applicants for Integrated Projects include:

  • Colleges and universities

  • 1994 Land-Grant Institutions

  • Hispanic-Serving Agricultural Colleges and Universities

Only public or nonprofit, accredited institutions are eligible to apply directly.

Other entities may participate as subcontractors or partners. If you are a for profit business with technology relevant and need assistance finding a partner, please contact robert@bwcoconsulting.com.

What companies and projects are likely to win?

Successful projects typically:

  • Address a clearly defined SAS sub-priority aligned with USDA priorities

  • Demonstrate full integration of research, education, and extension

  • Use a systems-based and transdisciplinary approach

  • Engage farmers, producers, and stakeholders from project inception

  • Show measurable, long-term economic and agricultural impact

Are there any restrictions I should know about?

  • Projects must include research, education, and extension components

  • Indirect costs are capped at 30% of total federal funds awarded

  • Funds may not be used for construction, renovation, or facility acquisition

  • Certain applied research projects may require dollar-for-dollar matching funds, depending on scope and commodity specificity

How long will it take me to prepare an application?

Applicants should expect a significant preparation effort, typically 8–12+ weeks, due to the scale of funding, required partnerships, integrated project design, and extensive narrative, budget, data management, and management plan requirements.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Flat fee pricing available upon request.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

See the solicitation here.

Read More
Active, Broad Topic Josiah Wegner Active, Broad Topic Josiah Wegner

FBI Enterprise Technology Broad Agency Announcement (BAA) – Federal Bureau of Investigation (FBI)

Deadline: Rolling through May 16th, 2027

Funding Award Size: $500k - $2m

Description: Funding for innovative R&D solutions supporting FBI enterprise technology problem sets, including AI, cybersecurity, biometrics, counterintelligence, and data fabric.

Updated October 2026: A June 10, 2026 notice extended the FBI Enterprise Problem Sets BAA through May 16, 2027.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The FBI’s Enterprise Technology Broad Agency Announcement (BAA) is open through May 16, 2026 and accepts white paper submissions at any time during the open period. The program seeks innovative R&D concepts from industry and academia across multiple FBI problem sets (including AI, cybersecurity, biometrics, counterintelligence, digital exploitation, and enterprise data fabric). Submissions are emailed to BAA@FBI.GOV and follow a two-step process: Step 1 is a white paper (or recorded oral presentation), and selected applicants may be invited to Step 2 to submit a full proposal.

How much funding is available?

Although not explicitly mentioned in the solicitation, typical awards range from $500k to $2m for periods of performance ranging from 6-24 months

What could I use the funding for?

Funding supports R&D efforts aligned to the FBI’s “Problem Set Areas”. See an overview below and full description here:

1. Leverage Artificial Intelligence (AI) and its Sub-Fields

  • Content Extraction and Triage

  • All-Source Data Management

  • Workflow Automation

  • Actionable Analysis and Alerting

  • Semi-Autonomous Multi-Sensor Fusion

  • Business Operations

  • Data Science

  • Knowledge Management

  • Open-Source Information Gathering

  • Correspondence Management from Multiple Sources

  • Dynamic Threat Analysis

  • Human Resource (HR) Recruiting

  • Signature Identification

  • Cybersecurity

  • Artificial Intelligence (AI) Governance

2. Enhance Counterintelligence and Security

  • Counterintelligence (CI) Capability

  • Personnel Assessment and Evaluation

  • Cyber Behavior

  • Foreign Contacts

3. Mission-Enhancing Science and Technology

  • Digital Exploitation

    • Document and Media Acquisition

    • Human Language Technologies

    • Computer Vision

    • Digital Signals Processing

    • Data, Process, and User Artifact Analysis

    • Document and Media Exploitation (DOMEX)

  • Directed Energy Weapons (DEW)

  • Biometrics

  • Weapons of Mass Destruction

  • Electro-Optical Detection

  • Pulsed Power Detection

  • Radio Frequency Detection

4. Improve Mission Support Capabilities

  • Information Technology (IT)

    • IT Governance

    • Data Management and Analytics

    • Infrastructure and Cloud Management

    • Information Assurance and Cyber Defense

    • Operations Support

    • Strategic Information and Operations (SIOC)

  • Cyber Capability Requirements Process

  • Enterprise Common Data Fabric Solutions

5. Increase Organizational Effectiveness

  • Performance Management

    • Applicant Screening

    • Career Advancement

    • Workplace Learning and Performance

Are there any additional benefits I would receive?

Beyond the formal funding award, there are meaningful indirect benefits to winning an FBI BAA award:

  • Government validation and mission alignment: Selection indicates the FBI sees strong technical merit and mission value in your R&D approach, which can accelerate future government relationships and contracting credibility.

  • Partnership acceleration: The FBI explicitly encourages partnering among industry and Government to speed adoption of new science and technology into fielded systems—awardees may benefit from stronger collaboration opportunities.

  • Higher valuation via nondilutive R&D: Funding supports R&D without equity dilution, allowing companies to mature technology and strengthen valuation narratives for future financing or acquisition (general commercial benefit; not explicitly stated in BAA).

  • Positioning for follow-on work: Award performance may strengthen eligibility and competitiveness for future FBI or broader federal procurements in adjacent mission areas.

What is the timeline to apply and when would I receive funding?

BAA open period: Effective 5/17/2023 – 05/16/2026.

  1. When to submit: White papers may be submitted at any time during the open period to BAA@FBI.GOV.

  2. Two-step process:

    • Step 1: Submit white paper

    • Step 2: If selected, FBI requests a formal proposal (do not submit full proposal unless requested)

  3. Selection timing: FBI may make selections anytime during the open period and up to six months after closing for white papers submitted during the open period.

  4. Funding receipt timing: Not specifically stated; awards depend on selection, negotiations, and funding availability.

Where does this funding come from?

This is a Federal Bureau of Investigation (FBI) Broad Agency Announcement run through the FBI Finance Division | Procurement Section.


The BAA is conducted under the Federal Acquisition Regulations (FAR) for R&D.

Who is eligible to apply?

The BAA is intended to encourage participation by:

  • Science and technology firms

  • Educational institutions

Additional eligibility-related requirements include:

  • Offerors must be registered in SAM prior to submission and maintain active SAM registration.

  • Offerors may propose subcontracting and teaming arrangements, including industry-academia and industry-government partnerships.

  • Submissions are generally expected to be UNCLASSIFIED, but classified approaches require prior FBI approval.

What companies and projects are likely to win?

The FBI evaluates white papers using three equal factors:

  • Technical Approach: strong scientific/technical merit, innovation, sound concept, awareness of state of the art, understanding scope, and potential FBI mission benefit.

  • Capabilities and Relevant Experience: evidence the team/facilities can execute and safeguard controlled unclassified/classified info (if applicable), and prior work can be leveraged.

  • Rough Order of Magnitude (ROM): cost realism based on total estimated labor, materials, subcontracts, ODCs, indirect, and fee/profit.

Are there any restrictions I should know about?

Key restrictions and compliance items include:

  • White paper page limit: written submissions must not exceed 10 pages (pages beyond are not evaluated).

  • Communications must be UNCLASSIFIED and emailed to BAA@FBI.GOV; do not email classified info.

  • Security requirements: work expected unclassified, but some efforts may require personnel clearable to Top Secret (TS) and potentially SCI access with NDAs and polygraph.

How long will it take me to prepare an application?

Not explicitly stated, but the required Step 1 white paper format suggests typical preparation time depends on complexity:

  • Written white paper: up to 10 pages plus additional sections (program plan, experience, ROM).

  • Alternative format: a pre-recorded oral presentation up to 10 minutes may be submitted instead of written format.

How can BW&CO help?

BW&CO can provide fractional or full support to increase the likelihood of success and save you a significant amount of time in the application process. Most clients don’t spend more than 3 hours a week in their engagement with us and our success rates are 2x-3x the national average. We collect your data, write an initial draft, have your team approve, and then move on to the next deliverable.

How much would BW&CO Charge?

Fractional support is $300 per hour. For full grant writing support, we would charge a $9,000 fee for submitting the initial white paper. If you receive an invitation for a full submission, there would be a follow-on payment of $9,000 to submit the full proposal with a 5% success fee contingent on award.

For startups, we offer a discounted rate of $250 per hour to make top-tier consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

See the solicitation here.

Read More
Inactive, Broad Topic Josiah Wegner Inactive, Broad Topic Josiah Wegner

AFRL Multiple Award Contract (AMAC) – Air Force Research Laboratory

Deadline: ClosedFebruary 27, 2026

Funding Award Size: $500 - $50 Million

Description: Funding vehicle enabling AFRL to award unclassified science and technology research task orders across air, space, cyber, and cross-cutting defense domains.

Updated October 2026: This opportunity is closed. The deadline for this opportunity has passed. Browse currently open opportunities in our funding database.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Air Force Research Laboratory (AFRL) AMAC program establishes a multiple-award IDIQ contract vehicle enabling qualified U.S. companies to compete for future AFRL-funded science and technology (S&T) research task orders. There is no funding awarded at the base contract level; funding is provided only through competitively awarded task orders after selection. Proposals are due February 27, 2026.

How much funding would I receive?

There is no fixed funding amount awarded at the base IDIQ level. Each awardee is guaranteed a minimum of $500 over the life of the contract. Actual funding is awarded later through individual task or delivery orders, which may range from small research efforts to very large programs. The estimated ceiling value across all AMAC contracts is $10 billion.

How does the program work?

AMAC is not a single grant but a long-term contract vehicle that allows AFRL to rapidly fund unclassified science and technology research through future task orders. If you meet the criteria, you will receive the long-term contract vehicle. Companies selected to the AMAC vehicle become eligible to compete for AFRL-funded projects covering basic and applied research, technology development, modeling and simulation, manufacturing, experimentation, integration, and technology transition. Importantly, there is no funding awarded upfront—all funding is issued later through individual task orders, each with its own scope, budget, and performance period.

Are there any additional benefits I would receive?

Beyond task-order funding, AMAC awardees gain several indirect but material benefits:

  • Government Validation and Credibility: Selection confirms AFRL validation of your company’s technical experience as a prime contractor.

  • Long-Term AFRL Access: Awardees are eligible to compete for AFRL task orders for up to 8 years.

  • Increased Visibility: Awardees become part of AFRL’s active R&D contractor ecosystem.

  • Non-Dilutive Growth: Task-order funding enables technology maturation without equity dilution.

  • Stronger Strategic Positioning: Proven AFRL work can enhance acquisition, partnership, and future DoD contracting opportunities.

What is the timeline to apply and when would I receive funding?

Proposals must be submitted by February 27, 2026 at 5:00 PM ET. Base IDIQ awards are made after evaluation. Funding is only received after winning individual task orders, which may be issued at any point during the contract’s ordering period.

Where does this funding come from?

Funding for task orders comes from AFRL directorates and partner agencies using AFRL as the contracting vehicle. The base AMAC contract itself does not carry dedicated funding.

Who is eligible to apply?

Eligible applicants include U.S.-based companies that can demonstrate qualifying prime contractor experience in federal S&T research. This includes:

  • Small businesses

  • Large businesses

  • Joint ventures

  • Universities and non-profits

Foreign-owned or foreign-influenced companies are not eligible unless formally approved through the National Industrial Security Program.

What companies will receive the contracting vehicle?

To receive an AMAC award, offerors must:

  • Be a responsible source under FAR Part 9

  • Submit a compliant proposal following Section L instructions

  • Achieve a validated minimum score of 1,000 points in the self-scoring technical experience evaluation here

  • Demonstrate prime contractor experience in AFRL technical Areas of Interest

  • Receive an Acceptable rating for both Technical Experience and Small Business Participation Commitment

There is no price competition at the base contract level.

Are there any restrictions I should know about?

Yes. Key restrictions include:

  • No classified work is permitted under the AMAC base contract

  • Only prime contractor experience counts toward technical scoring

  • Subcontractor experience does not qualify for scoring

How can BW&CO help?

The AMAC solicitation is fundamentally a compliance-driven, pass/fail process. AFRL has stated that any offeror who submits a fully compliant proposal and meets the minimum technical threshold will receive an AMAC contract—while even minor non-compliance can result in elimination, regardless of technical merit. BW&CO helps ensure your proposal is structured correctly, fully compliant, and strategically positioned so you don’t lose this opportunity due to avoidable errors.

How much would BW&CO Charge?

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

See the solicitation here.

Read More
Inactive, specific topic Josiah Wegner Inactive, specific topic Josiah Wegner

Chemical and Biological Technologies Fundamental Research BAA – Defense Threat Reduction Agency (DTRA)

Deadline: Closed

Funding Award Size: $300K to $5 Million+

Description: Funding for research advancing chemical and biological defense technologies to counter weapons of mass destruction threats.

Updated October 2026: This opportunity is closed. The umbrella BAA remains in force, but the current topic white paper window closed March 2, 2026 and no new topics have been posted. Browse currently open opportunities in our funding database.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Defense Threat Reduction Agency (DTRA) is accepting rolling submissions through 2034 for fundamental research projects that advance chemical and biological defense capabilities. This Broad Agency Announcement (BAA) supports basic and applied research addressing counter–weapons of mass destruction (C-WMD) challenges, with a current white paper deadline of March 2, 2026 for Topic Areas B1–B6.

How much funding would I receive?

$300,000 to $5 million depending on the topic.

What could I use the funding for?

For research and development that aligns with the topics below. For more details on each topic click here.

B1. Deriving Human Physiological Endpoints via Microphysiological Systems (MPS): Bridging the Gap for Predictive Translation

DTRA is seeking fundamental research that advances microphysiological systems (organs-on-a-chip) to derive reliable, human-relevant physiological endpoints that can be translated into real-world exposure detection. Projects should develop standardized, measurable physiological signals across multi-organ MPS platforms and link those signals to in-vivo human responses, particularly for early detection of chemical and biological exposures. Emphasis is placed on novel sensing technologies, data integration, and predictive algorithms rather than therapeutics or animal studies. Read full description here.

B2. Self-Improving AI Systems for Adaptive Defense

This topic funds research into AI systems that can autonomously adapt to new chemical and biological threats without human retraining. DTRA is specifically interested in self-modifying AI architectures that can safely update their own models, structures, or code while maintaining formally verified performance and safety guarantees. Projects must focus on foundational AI theory and methods—such as formal verification, containment, and meta-learning—rather than static or manually retrained detection systems. Read full description here.

B3. Quantum-Enhanced Topological Data Analysis for Chemical and Biological Defense

DTRA seeks interdisciplinary research combining quantum computing and topological data analysis to identify complex patterns in high-dimensional chemical and biological data that classical methods cannot detect. The goal is to enable earlier warning of engineered or novel threats, improve pathogen classification, and accelerate countermeasure discovery. Projects should focus on developing quantum-enabled analytical frameworks and demonstrating clear advantages over classical computational approaches. Read full description here.

B4. Advanced Repellent Materials for Omniphobic Resistance (ARMOR)

This topic supports fundamental research into durable, PFAS-free repellent materials for textiles that resist chemical and biological threats, oils, and industrial contaminants. DTRA is looking for new material chemistries and surface architectures—particularly reentrant or textured surfaces—that achieve strong oil repellency, mechanical durability, and safety for skin contact. Research should emphasize materials science, characterization methods, and performance against chemical simulants rather than full protective suit development. Read full description here.

B5. Sensing Engineered Chemical and Biological Threats with Synthetic Biology Designs

DTRA is funding early-stage research into synthetic biology-based sensing materials that enable rapid, adaptable detection of engineered or emerging biological threats. Projects should integrate computational design, AI/ML, and synthetic biology to create novel affinity reagents or sensing elements that outperform traditional antibodies in speed, adaptability, or stability. The focus is on proof-of-concept platforms and fundamental sensing science, not deployable sensor systems. Read full description here.

B6. Free-Standing Films Used as Detection Wipes

This topic seeks fundamental research on free-standing, self-indicating films that can be used as low-cost detection wipes for chemical threats on surfaces. DTRA is interested in understanding the structural, optical, and electrical properties of cross-linked polymer films embedded with non-dye-based recognition elements that change color upon exposure to chemical agents or simulants. Research should prioritize material synthesis, reproducibility, environmental robustness, and early prototype integration rather than full system fielding. Read full description here.

Are there any additional benefits I would receive?

Beyond the formal funding award, there are significant indirect benefits to receiving a DTRA fundamental research award:

Government Validation and Credibility: Selection by DTRA signals strong technical credibility and alignment with national counter-WMD priorities, which can accelerate trust with defense partners and future government sponsors.

Enhanced Visibility Within the Defense Research Community: Awardees are part of DTRA’s extramural research ecosystem, increasing exposure to DoD laboratories, academic collaborators, and future funding opportunities.

Nondilutive Technology Maturation: By advancing early-stage science with nondilutive funding, companies can de-risk core technology while preserving equity and strengthening long-term exit potential.

What is the timeline to apply and when would I receive funding?

For Topic Areas B1–B6, pre-application white papers are due March 2, 2026 at 11:59 PM EST. Submissions follow a two-phase process, with invited full proposals submitted after successful white paper review.

Where does this funding come from?

Funding is provided by the Department of Defense through the Defense Threat Reduction Agency (DTRA) under CFDA 12.351.

Who is eligible to apply?

Eligibility is defined at the topic level. In general, the BAA supports extramural performers conducting basic or applied research, including universities, industry, and other research organizations, subject to topic-specific requirements. is cost-shared by non-government sources

What companies and projects are likely to win?

Competitive projects typically:

  • Address high-impact chemical or biological defense challenges relevant to C-WMD

  • Advance fundamental scientific knowledge or revolutionary technical approaches

  • Align with early-stage research (TRLs 1–4)

  • Demonstrate strong scientific rigor and feasibility

  • Fit within DTRA’s stated thrust areas or published topic needs

Are there any restrictions I should know about?

Pre-application coordination is generally required before submitting a white paper, and submissions without coordination may not be reviewed. Proprietary product development and later-stage commercialization activities are outside the scope of this announcement.

How long will it take me to prepare an application?

Most first-time applicants (without any assistance from BW&CO) should plan for 40–60 hours of effort to prepare the white paper over 8–12 weeks, including technical writing, budget preparation, and internal reviews.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for $4000 Initial Fee for the white paper.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

Learn more about the program here.

Read More
Inactive, specific topic Josiah Wegner Inactive, specific topic Josiah Wegner

Compact Oxygen Generation Medical Devices (COGM / COGM-A) – Defense Health Agency (DHA)

Deadline: Closed

Funding Award Size: Est. $1M to $2M

Description: Funding to develop FDA-cleared compact medical oxygen generation devices for expeditionary and aeromedical military environments under a Defense Health Agency OTA.

Updated October 2026: This opportunity is closed. The deadline for this opportunity has passed. Browse currently open opportunities in our funding database.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Defense Health Agency (DHA) is soliciting prototype proposals to develop compact medical oxygen generation devices for use in austere and expeditionary military environments. This Other Transaction Authority (OTA) program supports the development of FDA-cleared oxygen generation systems for battlefield care and aeromedical evacuation. Proposals are due March 6, 2026.

How much funding would I receive?

Estimated $1-$2 million. The RPP does not specify a minimum or maximum award size. The government anticipates making multiple prototype OTA awards, with funding incrementally obligated over the period of performance. Total award size will depend on proposed scope, schedule, and cost realism.

What could I use the funding for?

The DHA needs to provide medical oxygen solutions in austere environments to treat service members with compromised lung function or injuries requiring oxygen therapy. The WEMT PMO is developing multiple oxygen generation and delivery systems through its Portable Oxygen (O2) program. This program aims to support casualties across all care settings, including evacuation platforms (Roles of Care 1-3 and en route). Development and approval of candidate solutions will adhere to the U.S. Food and Drug Administration (FDA), and other relevant regulatory and industry best practices.

This effort focuses on developing two expeditionary, easy-to-maintain oxygen generation devices meeting Joint Enroute Care Equipment Test Standard and airworthiness standards:

FOCUS AREA #1: Compact Oxygen Generation, Medical (COGM)

• Priority: High

• Primary Use: Role 1 (but still usable across all Roles, including en route care)

• Capabilities: Adjustable flow rate (3-7 lpm minimum, 15 lpm desired) for use with nasal cannulas, face masks, and nebulizers.

• Target Timeline: Regulatory approvals by 2029, procurement by 2031 (shorter timeline preferred)

FOCUS AREA #2: Compact Oxygen Generation, Medical – At Altitude (COGM-A)

• Primary Use: Aeromedical evacuation platforms

• Capabilities: Similar to COGM, but with adjustable flow up to 15 lpm and high-pressure output for ventilators.

• Target Timeline: Regulatory approvals by 2030, procurement by 2032 (shorter timeline preferred)

Are there any additional benefits I would receive?

Beyond the direct funding, awardees gain several strategic advantages:

Government Validation and Credibility:
Selection by the Defense Health Agency signals strong technical credibility and alignment with DoD operational medical priorities—often accelerating trust with military customers, primes, and investors.

Nondilutive Technology Advancement:
This OTA enables companies to mature medical devices without equity dilution, preserving cap table value while advancing toward procurement readiness.

Follow-On Production Potential:
Successful prototypes may lead directly to a follow-on production OTA, reducing acquisition friction and shortening the path to revenue.

Enhanced Defense Market Visibility:
Awardees become part of DHA’s Warfighter Expeditionary Medicine ecosystem, increasing exposure across DoD medical and acquisition communities..

What is the timeline to apply and when would I receive funding?

  1. Questions Due: February 6, 2026

  2. Proposals Due: March 6, 2026 (5:00 PM EST)

  3. Period of Performance:

    • Up to ~24 months for COGM

    • Up to ~36 months for COGM-A

Where does this funding come from?

This program is funded by the U.S. Department of Defense, administered through the Defense Health Agency (DHA) using Prototype Other Transaction Authority (10 U.S.C. §4022).

Who is eligible to apply?

To be eligible, proposals must meet at least one of the following OTA statutory conditions:

  • Include a nontraditional defense contractor or nonprofit research institution participating to a significant extent

  • All significant participants are small businesses or nontraditional defense contractors

  • At least one-third of total project cost is cost-shared by non-government sources

What companies and projects are likely to win?

Proposals are evaluated on three primary factors:

  • Strength and feasibility of the technical approach to meeting SOO requirements

  • Credibility of the management and execution plan, including regulatory and manufacturing readiness

  • Cost realism and completeness of the proposed budget

Projects starting near TRL 4 with a clear path to FDA clearance and military deployment are strongly aligned.

Are there any restrictions I should know about?

  • Proposals must comply with FDA medical device regulations

  • Foreign collaborators require additional justification

  • Participation in malign foreign talent programs is prohibited

  • Cost sharing rules apply if nontraditional or small business criteria are not met

  • Files must be submitted exactly as instructed; noncompliance may result in elimination

How long will it take me to prepare an application?

Most first-time applicants (without any assistance from BW&CO) should plan for 120–200 hours of effort over 8–12 weeks, including technical writing, budget preparation, and internal reviews.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for $13000 Initial Fee + 5% Success Fee.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

Learn more about the program here.

Read More
Active, Broad Topic Josiah Wegner Active, Broad Topic Josiah Wegner

ERDC BAA - ARMY

Deadline: Rolling until January 1, 2027

Funding Award Size: Est. $2-$10 Million

Description: Funding for research and development supporting military engineering, environmental science, infrastructure resilience, geospatial systems, computing, materials, energy, and related defense and civil works technologies.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The U.S. Army Corps of Engineers’ Engineer Research and Development Center (ERDC) is issuing a continuously open Broad Agency Announcement to fund basic, applied, and advanced research across a wide range of engineering, environmental, and defense-relevant technology areas. Awards are made on a rolling basis through cooperative agreements, subject to the availability of funds so interested companies should submit as soon as possible.

How much funding would I receive?

ERDC does not specify a standard award size. Individual awards may range from small research efforts to very large, multi-year programs, with an overall program ceiling of $1 billion. Funding levels are determined based on technical scope, relevance, and available funding within the sponsoring ERDC laboratory.

What could I use the funding for?

To be eligible for consideration and possible contract award, the technology or methodology shall be either basic research, applied research, advanced technology development not for a specific system/hardware, or demonstration and validation.


If your technology is novel and fits into one of the following Areas of Interest, you could potentially be funded:

Coastal and Hydraulics Laboratory (CHL)

Geotechnical & Structures Laboratory (CHL)

Environmental Sensing

Contaminated Site Characterization, Assessment & Remediation

Sediment Geochemistry and Biological Effects

Environmental and Water Quality Modeling

Environmental Impact Prediction, Assessment and Management

Environmental Criteria for Stream Channel Alteration Projects

More topics in progress (see solicitation for all topics).

Are there any additional benefits I would receive?

Beyond the direct funding, ERDC awards provide meaningful strategic advantages:

Government Validation and Technical Credibility:
Selection by ERDC signals strong alignment with U.S. Army and national infrastructure priorities, which can materially strengthen your credibility with customers, primes, and investors.

Non-Dilutive Technology Maturation:
Companies can advance core technology without equity dilution, preserving ownership while increasing enterprise value.

Long-Term Government Relationship Building:
ERDC BAAs are often a gateway into follow-on DoD contracts, reimbursable work, and sole-source opportunities.

Increased Visibility Across DoD and Civil Works:
Successful projects frequently expand beyond a single lab, creating exposure across USACE, DoD, and federal infrastructure stakeholders.

What is the timeline to apply and when would I receive funding?

This BAA is continuously open until January 1, 2027, and all submissions initially enter the process as pre-proposals. Pre-proposals may be submitted at any time through the ERDCWERX portal and are limited to five pages, plus a one-page executive summary.

ERDC conducts a preliminary technical review of pre-proposals as they are received. Offerors can expect a response within 60 days of submission, either encouraging submission of a full proposal or advising that the pre-proposal was not favorably reviewed.

If a pre-proposal receives a favorable review, ERDC will issue a formal invitation from the Contracting Office to submit a full proposal. Full proposals then undergo scientific peer review, cost evaluation, and funding availability assessment.

There is no fixed award cycle or batch deadline. Awards may be made at any time following successful evaluation and are subject to availability of funds.

Where does this funding come from?

Funding is provided by the U.S. Army Corps of Engineers (USACE) through its Engineer Research and Development Center (ERDC) and supported DoD research programs.

Who is eligible to apply?

Eligibility is unrestricted, meaning any qualified U.S. or international entity may apply, subject to statutory and regulatory requirements. This includes:

  • For-profit companies

  • Startups and small businesses

  • Universities and nonprofit research organizations

What companies and projects are likely to win?

ERDC evaluates proposals based on:

  • Clear alignment with ERDC mission and stated research areas

  • Strong scientific or technical merit

  • Demonstrated capability of the proposing team

  • Practical relevance to military or civil works challenges

  • Realistic scope and cost relative to expected outcomes

Are there any restrictions I should know about?

  • ERDC may limit awards based on funding availability in specific technical areas

  • Some projects may be subject to export control, security, or publication restrictions

  • Proposals must clearly identify whether research is considered “fundamental”

  • Full proposals must be submitted only through designated laboratory channels, not directly to technical staff

How long will it take me to prepare an application?

For a first-time applicant, preparing a competitive pre-proposal under this BAA will likely take 20–40 hours in total.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for a flat fee of $4,000 for the Pre-Proposal Submission.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

See solicitation on sam.gov

Read More